This site is no longer actively maintained. It remains posted for archive purposes only.

Emerging Infections Program Bibliography 1995-2003

On this page

About Open Access Articles

Note: Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.

Bibliography by Author: A - B

1. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.[see comment][erratum appears in J Pediatr. 2004 Mar;144(3):412]. Journal of Pediatrics 143(4):438-44, 2003.
   Open Access: http://www2.us.elsevierhealth.com/scripts/om.dll/serve?
   action=searchDB&searchDBfor=art&artType=full&id=as0022347603003317 For more information: The Journal of Pediatrics.
2. Albanese BA, Roche JC, Pass M, Whitney CG, McEllistrem MC, Harrison LH, for the Maryland Emerging Infections Program. Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clinical Infectious Diseases 2002; 34(1):15-21.
   Open Access: http://www.journals.uchicago.edu/CID/journal/issues/v34n1/010172/010172.html
3. Allos BM, Moore MR, Griffin PM, Tauxe RV. Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. Clinical Infectious Diseases 2004; 38(Suppl 3):S115-120.
   Open access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32103/32103.html
4. Angulo FJ, Voetsch AC, Vugia D, Hadler JL, Farley M, Hedberg C et al. Determining the burden of human illness from food borne diseases. CDC's emerging infectious disease program Food Borne Diseases Active Surveillance Network (FoodNet). Veterinary Clinics of North America - Food Animal Practice 1998; 14(1):165-172.
5. Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA et al. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrobial Agents & Chemotherapy 46(8):2477-81, 2002.
   Open Access: http://aac.asm.org/cgi/content/full/46/8/2477?maxtoshow=&HITS=10&hits=10&
   RESULTFORMAT=&author1=skaggs,+ba&searchid=1062612471707_2049&stored_search=&FIRSTINDEX=
   0&search_url=http://aac.asm.org/cgi/search&journalcode=aac
6. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A et al. Genome and virulence determinants of high virulence community-acquired MRSA.[see comment]. Lancet 59(9320):1819-27, 2002.
   Reprinted from THE LANCET, Vol.359, Baba T et al., “Genome and virulence determinants of high virulence community-acquired MRSA”, ©2002, with permission from Elsevier. http://www.thelancet.com Download PDF [9 pages, 1.46 MB]
7. Baer JT, Vugia DJ, Reingold AL, Aragon T, Angulo FJ, Bradford WZ. HIV infection as a risk factor for
   shigellosis. Emerging Infectious Diseases 1999; 5(6):820-823.
8. Bakardjiev A, Glaser C, Schuster F, Visvesvara GS. Three-year-old girl with fever and coma. Pediatric Infectious Disease Journal 21(1):75, 85-6, 2002. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [12 pages, 270 MB]
9. Bakardjiev A, Azimi PH, Ashouri N, Ascher DP, Janner D, Schuster FL et al. Amebic encephalitis caused by Balamuthia mandrillaris: report of four cases. Pediatric Infectious Disease Journal 2003; 22(5):447-453. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 353 KB]
10. Balter S, Zell ER, O'Brien KL, Roome A, Noga H, Thayu M et al. Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatric Infectious Disease Journal 22(10):853-7, 2003. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 208 KB]
11. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group
    B streptococcal prevention. Pediatrics 2001; 108(5):1094-1098.
12. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology 1996; 34(4):953-958.
    Open Access :
    http://jcm.asm.org/cgi/content/abstract/34/4/953?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&
    author1=beall,+b&searchid=1062613942902_3880&stored_search=&FIRSTINDEX=10&search_url=http://
    jcm.asm.org/cgi/search&journalcode=jc
13. Beall B, Facklam R, Hoenes T, Schwartz B. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. Journal of Clinical Microbiology 1997; 35(5):1231-1235. Open Access:http://jcm.asm.org/cgi/content/abstract/35/5/1231?
    maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=beall,+b&searchid=1062613942902_3880&stored_search=&FIRSTINDEX=10&search_
    url=http://jcm.asm.org/cgi/search&journalcode=jcm
14. Beall B, Facklam RR, Elliott JA, Franklin AR, Hoenes T, Jackson D et al. Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. Journal of Medical Microbiology 1998; 47(10):893-898.
    Posted with permission from the International Union of Microbiological Societies. Download PDF [8 pages, 922 KB]
15. Beall B, Gherardi G, Lovgren M, Facklam RR, Forwick BA, Tyrrell GJ. emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 2000; 146(Pt 5):1195-1209.
    Open Access: http://mic.sgmjournals.org/cgi/content/full/146/5/1195?view=long&pmid=10832648
16. Beall B, McEllistrem MC, Gertz RE, Jr., Boxrud DJ, Besser JM, Harrison LH, Jorgensen JH, Whitney CG, for the Active Bacterial Core Surveillance/ Emerging Infections Program Network. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. Journal of Infectious Diseases 2002; 186(1):118-122.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v186n1/011524/011524.html
17. Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. New England Journal of Medicine 1997; 337(6):388-394.
18. Bender JB, Smith KE, Hedberg C, Osterholm MT. Food-borne disease in the 21st century. What challenges await us?. [Review] [15 refs]. Postgraduate Medicine 1999; 106(2):109-112.
    Open access: http://www.postgradmed.com/issues/1999/08_99/bender.htm
19. Bender JB, Hedberg CW, Boxrud DJ, Besser JM, Wicklund JH, Smith KE et al. Use of molecular subtyping in surveillance for Salmonella enterica serotype typhimurium. New England Journal of Medicine 2001; 344(3):189-195.
20. Bender JB, Smith KE, McNees AA, Rabatsky-Ehr TR, Segler SD, Hawkins MA et al. Factors affecting surveillance data on Escherichia coli O157 infections collected from FoodNet sites, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S157-164.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32109/32109.html
21. Berkelman RL, Pinner RW, Hughes JM. Addressing emerging microbial threats in the United States. JAMA 1996; 275(4):315-317.
22. Binder S, Khabbaz R, Swaminathan B, Tauxe R, Potter M. The national food safety initiative. Emerging Infectious Diseases 1998; 4(2):347-351.
23. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease
    in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerging Infectious Diseases 1998; 4(2):229-237.
24. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129(9):698-704.
    Open Access:http://www.annals.org/cgi/content/full/129/9/698
25. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR et al. Invasive group B streptococcal disease: the emergence of serotype V. Journal of Infectious Diseases 1996; 173(2):365-373.
26. Brandt ME, Hutwagner LC, Kuykendall RJ, Pinner RW. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group. Journal of Clinical Microbiology 1995; 33(7):1890-1895.
    Open access:http://jcm.asm.org/cgi/content/abstract/33/7/1890?maxtoshow=&HITS=10&hits=10&
    RESULTFORMAT=&author1=brandt,+me&searchid=1062612714885_3819&stored_search=&FIRSTINDEX=
    0&search_
    url=http://jcm.asm.org/cgi/search&journalcode=jc
27. Brandt ME, Pfaller MA, Hajjeh RA, Graviss EA, Rees J, Spitzer ED et al. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group. Journal of Infectious Diseases 1996; 174(4):812-820.
28. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EA et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. Journal of Clinical Microbiology 1996; 34(4):912-917.
    Open access: http://jcm.asm.org/cgi/content/abstract/34/4/912?maxtoshow=&HITS=10&hits=10&
    RESULTFORMAT=&author1=brandt,+me&searchid=1062612714885_3819&stored_search=&FIRSTINDEX=
    0&search_url=http://jcm.asm.org/cgi/search&journalcode=jc
29. Brandt ME, Harrison LH, Pass M, Sofair AN, Huie S, Li RK et al. Candida dubliniensis fungemia: the first
    four cases in North America. Emerging Infectious Diseases 2000; 6(1):46-49.
30. Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL et al.Trends in antifungal drug
    susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrobial Agents & Chemotherapy 2001; 45(11):3065-3069. (Open access)
31. Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Archives of Internal Medicine 2000; 160(17):2633-2638.
32. Bryan RT, Pinner RW, Berkelman RL. Emerging infectious diseases in the United States, Improved surveillance, a requisite for prevention. [Review] [38 refs]. Annals of the New York Academy of Sciences 1994; 740:346-361.
    Posted with permission. For more information, visit www.nyas.org and www.annalsnyas.org
    Download PDF [16 pages, 1.9 MB]
33. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. Journal of Infectious Diseases 1996; 174(5):986-993.
34. Butler JC, Bosshardt SC, Phelan M, Moroney SM, Tondella ML, Farley MM, Schuchat A, Fields BS. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. Journal of Infectious Diseases 187(9):1416-23, 2003.
    Open access: http://www.journals.uchicago.edu/JID/journal/issues/v187n9/30218/30218.html

To Top




Bibliography by Author: C

35. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae
    type b disease among infants and children--United States, 1993-1994. MMWR Morb Mortal Wkly Rep 1995; 44(29):545-550.
36. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae
    type b disease among infants and children--United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996; 45(42):901-906.
37. Centers for Disease Control and Prevention. Serogroup Y meningococcal disease--Illinois, Connecticut,
    and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep 1996; 45(46):1010-1013.
38. Centers for Disease Control and Prevention. Assessment of national reporting of drug-resistant
    Streptococcus pneumoniae--United States, 1995-1996. MMWR Morb Mortal Wkly Rep 1996; 45(43):947-949.
39. Centers for Disease Control. Prevention of perinatal group B streptococcal
    disease: a public health
    perspective. Centers for Disease Control and Prevention. [erratum appears in MMWR Morb Mortal Wkly Rep 1996 Aug 9;45(31):679.]. MMWR - Morbidity & Mortality Weekly Report 1996; 45(RR-7):1-24.
40. Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease--United States. MMWR Morb Mortal Wkly Rep 1996; 45(31):665-668.
41. Centers for Disease Control and Prevention. Decreasing incidence of perinatal Group B streptococcal
    disease--United States, 1993-1995. MMWR Morb Mortal Wkly Rep 1997; 46(21):473-477.
42. Centers for Disease Control. Foodborne Diseases Active Surveillance Network, 1996. MMWR - Morbidity & Mortality Weekly Report 1997; 46(12):258-261.
43. Centers for Disease Control and Prevention. Foodborne Diseases Active Surveillance Network (FoodNet). Emerging Infectious Diseases 1997; 3(4):581-583.
44. Centers for Disease Control and Prevention. Outbreak of cryptosporidiosis associated with a water
    sprinkler fountain--Minnesota, 1997. MMWR Morb Mortal Wkly Rep 1998; 47(40):856-860.
45. Centers for Disease Control. Incidence of foodborne illnesses--FoodNet, 1997. MMWR - Morbidity & Mortality Weekly Report 1998; 47(37):782-786.
46. Centers for Disease Control. From the Centers for Disease Control and Prevention. Incidence of foodborne illnesses--FoodNet, 1997. JAMA 1998; 280(19):1651-1652.
47. Centers for Disease Control and Prevention. Haemophilus influenzae invasive disease among children aged
    <5 years--California, 1990-1996. MMWR - Morbidity & Mortality Weekly Report 1998; 47(35):737-740.
48. Centers for Disease Control and Prevention. Statewide surveillance for ehrlichiosis--Connecticut and New
    York, 1994-1997. MMWR - Morbidity & Mortality Weekly Report 1998; 47(23):476-480.
49. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group
    B streptococcal disease--United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47(32):665-670.
50. Centers for Disease Control and Prevention. Outbreaks of Shigella sonnei infection associated with eating
    fresh parsley--United States and Canada, July-August 1998. MMWR - Morbidity & Mortality Weekly Report 1999; 48(14):285-289.
51. Centers for Disease Control. Laboratory practices for prenatal Group B streptococcal screening and
    reporting--Connecticut, Georgia, and Minnesota, 1997-1998. MMWR Morb Mortal Wkly Rep 1999; 48(20):426-428.
52. Centers for Disease Control. Incidence of foodborne illnesses: preliminary data from the Foodborne
    Diseases Active Surveillance Network (FoodNet)--United States, 1998. MMWR - Morbidity & Mortality Weekly Report 1999; 48(9):189-194.
53. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine--
    United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48(27):577-581.
54. Centers for Disease Control. Geographic variation in penicillin resistance in Streptococcus pneumoniae--
    selected sites, United States, 1997. MMWR - Morbidity & Mortality Weekly Report 1999; 48(30):656-661.
55. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children--
    United States, 1990-1998. MMWR - Morbidity & Mortality Weekly Report 48(12):243-8, 1999.
56. Centers for Disease Control. FoodNet reports decline in some foodborne disease. Journal of the American Veterinary Medical Association 2000; 216(12):1892.
57. Centers for Disease Control. Preliminary FoodNet data on the incidence of foodborne illnesses--selected
    sites, United States, 1999. [erratum appears in MMWR Morb Mortal Wkly Rep 2000 Apr 7;49(13):286.]. MMWR Morb Mortal Wkly Rep 2000; 49(10):201-205.
58. Centers for Disease Control and Prevention. Unexplained illness and death among injecting-drug users--
    Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49(22):489-492.
59. Centers for Disease Control. From the Centers for Disease Control and Prevention. Preliminary Foodnet data on the incidence of foodborne illnesses--selected sites, United States, 1999. JAMA 2000; 283(14):1818-1819.
60. Centers for Disease Control and Prevention. Human rabies--California, Georgia, Minnesota, New York,
    and Wisconsin, 2000. MMWR - Morbidity & Mortality Weekly Report 49(49):1111-5, 2000.
61. Centers for Disease Control and Prevention. Adoption of perinatal group B streptococcal disease
    prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998. MMWR Morb Mortal Wkly Rep 2000; 49(11):228-232.
62. Centers for Disease Control and Prevention. Suspected brucellosis case prompts investigation of possible
    bioterrorism-related activity--New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Wkly Rep 2000; 49(23):509-512.
63. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among
    injecting-drug users--Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49(24):543-545.
64. Centers for Disease Control. Hospital-based policies for prevention perinatal Group B streptococcal
    disease--United States, 1999. [erratum appears in MMWR Morb Mortal Wkly Rep 2000 Oct 27;49(42):966.]. MMWR - Morbidity & Mortality Weekly Report 2000; 49(41):936-940.
65. Centers for Disease Control. Laboratory capacity to detect antimicrobial resistance, 1998. MMWR Morb Mortal Wkly Rep 2000; 48(51-52):1167-1171.
66. Centers for Disease Control. From the Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses--selected sites, United States, 2000. JAMA 2001; 285(16):2071-2073.
67. Centers for Disease Control. Resistance of Streptococcus pneumoniae to fluoroquinolones
    --United States, 1995-1999. MMWR - Morbidity & Mortality Weekly Report 2001; 50(37):800-804.
68. Centers for Disease Control and Prevention. Update: Unexplained deaths following knee surgery
    --Minnesota, 2001. MMWR Morb Mortal Wkly Rep 2001; 50(48):1080.
69. Centers for Disease Control. Preliminary FoodNet data on the incidence of foodborne illnesses
    --selected sites, United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50(13):241-246.
70. From the Centers for Disease Control and Prevention. Update: allograft-associated bacterial infections-- United States, 2002. JAMA 2002; 287(13):1642-1644.
71. Centers for Disease Control and Prevention. Assessment of susceptibility testing practices for
    Streptococcus pneumoniae--United States, February 2000. MMWR Morb Mortal Wkly Rep 2002; 51(18):392-394.
72. Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections
    --United States, 2002. MMWR - Morbidity & Mortality Weekly Report 2002; 51(10):207-210.
73. Centers for Disease Control and Prevention. Serotyping discrepancies in Haemophilus influenzae
    type b disease--United States, 1998-1999. MMWR - Morbidity & Mortality Weekly Report 51(32):706-7, 2002.
74. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae
    type b invasive disease among infants and children--United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002; 51(11):234-237.
75. Centers for Disease Control. Preliminary FoodNet data on the incidence of foodborne illnesses--selected
    sites, United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51(15):325-329. Centers for Disease Control and Prevention (CDC).
76. Centers for Disease Control and Prevention. Preliminary FoodNet Data on the Incidence of Foodborne
    Illnesses --- Selected Sites, United States, 2002. MMWR 2003;52(15):340-343.
77. Centers for Disease Control and Prevention (CDC). Severe morbidity and mortality associated with
    influenza in children and young adults--Michigan, 2003. MMWR Morbidity & Mortality Weekly Report 2003; 52(35):837-840.
78. Centers for Disease Control and Prevention (CDC). Diminishing racial disparities in early-onset neonatal
    group B streptococcal disease--United States, 2000-2003. MMWR 2004; Morbidity & Mortality Weekly Report. 53(23):502-505.
79. Centers for Disease Control and Prevention (CDC). Laboratory practices for prenatal group B
    streptococcal screening--seven states, 2003. MMWR 2004; Morbidity & Mortality Weekly Report. 53(23):506-509.
80. Centers for Disease Control and Prevention (CDC). Effect of new susceptibility breakpoints on
    reporting of resistance in Streptococcus pneumoniae--United States, 2003. MMWR Morbidity & Mortality Weekly Report 2004; 53(7):152-154.
81. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of
    infection with pathogens transmitted commonly through food--selected sites, United States, 2003. MMWR Morbidity & Mortality Weekly Report 2004; 53(16):338-343.
82. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of
    infection with pathogens transmitted commonly through food--10 sites, United States, 2004. MMWR Morbidity & Mortality Weekly Report 54(14):352-6, 2005.
83. Chang HG, Tserenpuntsag B, Kacica M, Smith PF, Morse DL. Hemolytic uremic syndrome incidence in
    New York. Emerging Infectious Diseases 2004; 10(5):928-931.
84. Chaput EK, Meek JI, Heimer R. Spatial Analysis of Human Granulocytic Ehrlichiosis near Lyme, Connecticut. Emerging Infectious Diseases 8(9):943-8, 2002.
85. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin B, Chambers HF . Origins of community strains of methicillin-resistant Staphylococcus aureus.[erratum appears in Clin Infect Dis. 2004 Jul 15;39(2):291 Note: Edlin, B [corrected to Edlin, BR]]. Clinical Infectious Diseases 39(1):47-54, 2004.
    Open access:http://www.journals.uchicago.edu/CID/journal/issues/v39n1/32585/32585.html
    Open access link for erratum: http://www.journals.uchicago.edu/CID/journal/issues/v39n2/34274/
    34274.html
86. Chatterjee NK, Moore DW, Monroe SS, Glass RI, Cambridge MJ, Kondracki SF, Morse DL . Molecular epidemiology of outbreaks of viral gastroenteritis in New York State, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S303-310.
    Open access: http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32127/32127.html
87. Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, Cetron MS. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. American Journal of Epidemiology 1998; 148(12):1212-1218.
88. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW. Tracking drug-resistant
    Streptococcus
    pneumoniae in Oregon: an alternative surveillance method. Emerging Infectious Diseases 1999; 5(5):688-693.
89. Chu FK. Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis. Mol Cell Probes 1998; 12(2):93-99.
90. Chuang I, Van Beneden C, Beall B, Schuchat A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clinical Infectious Diseases 35(6):665-70, 2002.
    Open access: http://www.journals.uchicago.edu/CID/journal/issues/v35n6/020203/020203.html
91. Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM. Vancomycin in Oregon: who's using it and why. Infect Control Hosp Epidemiol 1999; 20(8):557-560.
92. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 2002; 155(10):941-948.

To Top




Bibliography by Author: D - H

93. Danila RN, Lexau C, Lynfield R, Moore KA, Osterholm MT. Addressing emerging infections. The partnership
    between public health and primary care physicians. [Review] [15 refs]. Postgraduate Medicine 1999; 106(2):90-92. (Open access)
94. Deneen VC, Hunt JM, Paule CR, James RI, Johnson RG, Raymond MJ et al. The impact of foodborne calicivirus disease: the Minnesota experience. Journal of Infectious Diseases 2000; 181(Suppl 2):281-283.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v181nS2/990757/990757.web.pdf
95. Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. [see comments.]. JAMA 1999; 281(16):1493-1497.
96. Dietz V, Vugia D, Nelson R, Wicklund J, Nadle J, McCombs KG et al. Active, multisite, laboratory-based surveillance for Cryptosporidium parvum. American Journal of Tropical Medicine & Hygiene 2000; 62(3):368-372.
    Posted with permission from The American Society of Tropical Medicine and Hygiene. Download PDF [5 pages, 343 KB]
97. Dunnebacke TH, Schuster FL, Yagi S, Booton GC. Isolation of Balamuthia amebas from the environment. Journal of Eukaryotic Microbiology 50 Suppl:510-1, 2003.
98. Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Preventive Medicine 2001; 32(5):409-415.
    Reprinted from Preventative Medicine, Vol. 32, Ehresmann et al., 409-415, ©2001, with permission from Elsevier. Download PDF [7 pages, 62 KB]
99. Eldridge BF, Glaser C, Pedrin RE, Chiles RE. The first reported case of California encephalitis in more than
    50 years. Emerging Infectious Diseases 2001; 7(3):451-452.
100. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E et al. emm typing and validation of
     provisional M types for group A streptococci. Emerging Infectious Diseases 5(2):247-53, 1999.
101. Factor SH, Whitney CG, Zywicki SS, Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstetrics & Gynecology 2000; 95(3):377-382.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 176 KB]
102. Farley MM. Group B streptococcal disease in nonpregnant adults. Clinical Infectious Diseases 2001; 33(4):556-561.
     Open Access: http://www.journals.uchicago.edu/CID/journal/issues/v33n4/010139/010139.htm
103. Farley MM, Baughman W, Arnold KE. The Georgia Emerging Infections Program: monitoring trends in invasive pneumococcal disease. Journal of the Medical Association of Georgia 91(2):20-3, 2002.
     Open access:http://www.journals.uchicago.edu/CID/journal/issues/v33n4/010139/010139.htm
104. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health 2000; 90(2):223-229.
     Copyright held by APHA, posted with permission Download PDF [7 pages, 168 KB]
105. Finn R, Groves C, Coe M, Pass M, Harrison LH. Cluster of serogroup C meningococcal disease associated with attendance at a party. Southern Medical Journal 2001; 94(12):1192-1194.
     Posted with permission of Lippincott, Williams & Wilkins. Download PDF [3 pages, 480 KB]
106. Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A . Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clinical Infectious Diseases 2000; 30(1):71-77.
     Open access:http://www.journals.uchicago.edu/CID/journal/issues/v30n1/990542/990542.htm
107. Fiorentino TR, Beall B, Mshar P, Bessen DE. A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. Journal of Infectious Diseases 1997; 176(1):177-182.
     Open access: http://www.journals.uchicago.edu/JID/journal/issues/v176n1/jy21_177/jy21_177.web.pd
108. Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatric Infectious Disease Journal 1997; 16(10):979-983. Reprinted with permission from Lippincott, Williams & Wilkins.
109. Flannery B, Stephanie Schrag, Nancy M.Bennett, Ruth Lynfield, Lee H.Harrison, Arthur Reingold et al. Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae Infections. JAMA 291, 2197-2203. 2004.
110. Frenzen PD, DeBess EE, Hechemy KE, Kassenborg H, Kennedy M, McCombs K et al. Consumer acceptance of irradiated meat and poultry in the United States. Journal of Food Protection 2001; 64(12):2020-2026.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: US Department of Agriculture, Oregon Health Div., NY State Dept. of Health, MN Dept. of Health, GA Div. of Public Health, CA Emerging Infections Program, CDC. Download PDF [7 pages, 130 KB]
111. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. Methicillin-resistant Staphylococcus aureus disease in three communities.[see comment]. New England Journal of Medicine 352(14):1436-44, 2005.
112. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, Reddy S, Ahuja SD, Helfrick DL, Hardnett F, Carter M, Anderson B, Tauxe RV, for the Emerging Infections Program FoodNet Working Group . Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S285-296.
     Open Access: http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32125/32125.htm
113. Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men. American Journal of Public Health 2000; 90(12):1942-1946.
     Copyright held by APHA, posted with permission Download PDF [5 pages, 106 KB]
114. Fry AM, Zell ER, Schuchat A, Butler JC, Whitney CG. Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine 21(3-4):303-11, 2002. Reprinted from Vaccine, Vol. 21, Fry et al., “Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly”, p. 303-11, ©2002, with permission from Elsevier.
     http://www.sciencedirect.com/science/journal/0264410X Download PDF [9 pages, 124 KB]
115. Fry AM, Facklam RR, Whitney CG, Plikaytis BD, Schuchat A. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. Journal of Infectious Diseases 188(5):643-52, 2003.
     Open access:http://www.journals.uchicago.edu/JID/journal/issues/v188n5/30619/30619.htm
116. Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, Farley MM, Tenover F, Stephens DS . The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. Journal of Infectious Diseases 2000; 182(5):1417-1424. Open access: http://www.journals.uchicago.edu/JID/journal/issues/v182n5/000066/
     000066.htm
117. Gertz RE, Jr., McEllistrem MC, Boxrud DJ, Li Z, Sakota V, Thompson TA et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. Journal of Clinical Microbiology 2003; 41(9):4194-4216.
     Open access: http://jcm.asm.org/cgi/content/full/41/9/419
118. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. Journal of Infectious Diseases 2000; 181(1):216-229.
     Open access: http://www.journals.uchicago.edu/JID/journal/issues/v181n1/990625/990625.htm
119. Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clinical Infectious Diseases 2003; 36(6):731-742.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v36n6/30040/30040.htm
120. Glynn MK, Reddy V, Hutwagner L, Rabatsky-Ehr T, Shiferaw B, Vugia DJ, Segler S, Bender J, Barrett TJ, Angulo FJ, and the Emerging Infections Program FoodNet Working Group . Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. Clinical Infectious Diseases 2004; 38(Suppl 3):S227-236.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32118/32118.htm
121. Greene CM, Van Beneden CA, Javadi M, Skoff TH, Beall B, Facklam R et al. Cluster of deaths from group A streptococcus in a long-term care facility-- Georgia, 2001. American Journal of Infection Control 33(2):108-13, 2005.
122. Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286(10):1201-5, 2001.
123. Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR et al. Antimicrobial resistance among
     Campylobacter strains, United States, 1997-2001.[see comment]. Emerging Infectious Diseases 10(6):1102-9, 2004.
124. Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: current controversies. [see comments.]. Obstetrics & Gynecology 2000; 96(1):141-145.
     Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 193 KB]
125. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas, PG, Thomas C, Reingold, A, Rothrick, G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW, and the Cryptococcal Active Surveillance Group. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. [see comments.]. Journal of Infectious Diseases 1999; 179(2):449-454.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v179n2/980816/980816.html
126. Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J et al.Surveillance for unexplained deaths
     and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerging Infectious Diseases 8(2):145-53, 2002.
127. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. Journal of Clinical Microbiology 42(4):1519-27, 2004.
     Open Access:http://jcm.asm.org/cgi/content/full/42/4/1519
128. Hall JA, Goulding JS, Bean NH, Tauxe RV, Hedberg CW. Epidemiologic profiling: evaluating foodborne outbreaks for which no pathogen was isolated by routine laboratory testing: United States, 1982-9. Epidemiology & Infection 127(3):381-7, 2001.
     Reprinted with permission from Cambridge University Press. Download PDF [7 pages, 142 KB]
129. Halsey NA, Schuchat A, Oh W, Baker CJ. The 1997 AAP guidelines for prevention of early-onset group B
     streptococcal disease. American Academy of Pediatrics. [see comments.]. Pediatrics 1997; 100(3):383-384.
130. Hardnett FP, Hoekstra RM, Kennedy M, Charles L, Angulo FJ, Emerging Infections Program FoodNet Working Group. Epidemiologic issues in study design and data analysis related to FoodNet activities. Clinical Infectious Diseases 2004; 38(Suppl 3):S121-126.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32131/32131.html
131. Harrison LH, Ali A, Dwyer DM, Libonati JP, Reeves MW, Elliott JA et al. Relapsing invasive group B streptococcal infection in adults. [see comments.]. Annals of Internal Medicine 1995; 123(6):421-427.
     Open Access:http://www.annals.org/cgi/content/full/123/6/421
132. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. Journal of Infectious Diseases 1998; 177(4):998-1002.
     Open Access:
     http://www.journals.uchicago.edu/JID/journal/issues/v177n4/ap46_998/ap46_998.web.pdf
133. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. [erratum appears in JAMA 2000 May 24-31;283(20):2659.]. JAMA 1999; 281(20):1906-1910.
134. Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Archives of Internal Medicine 2000; 160(1):89-94.
135. Harrison LH. Preventing meningococcal infection in college students. Clin Infect Dis 2000; 30(4):648-651.
     Open-access:http://www.journals.uchicago.edu/CID/journal/issues/v30n4/000029/000029.html
136. Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, Bustamante A et al. Invasive meningococcal disease in adolescents and young adults. [see comments.]. JAMA 2001; 286(6):694-699.
137. Hedberg CW, MacDonald KL, Osterholm MT. Changing epidemiology of food-borne disease: a Minnesota perspective. [Review] [18 refs]. Clinical Infectious Diseases 18(5):671-80; quiz 681-2, 1994.
138. Hedberg CW, Hirschhorn N. Why foodborne disease surveillance is critical to the safety of our food supply. Am J Public Health 1996; 86(8 Pt 1):1076-1077.
     Copyright held by APHA, posted with permission Download PDF [3 pages, 188 KB]
139. Hedberg CW. Foodborne disease: how to respond? Med J Aust 1996; 165(11-12):667.
     Reproduced with permission, ©1996. The Medical Journal of Australia Download PDF [1 page, 225 KB]
140. Hedberg CW, Angulo FJ, White KE, Langkop CW, Schell WL, Stobierski MG et al. Outbreaks of salmonellosis associated with eating uncooked tomatoes: implications for public health. The Investigation Team. Epidemiol Infect 1999; 122(3):385-393.
     Reprinted with the permission of Cambridge University Press Download PDF [9 pages, 238 KB]
141. Hedberg CW, Smith KE, Besser JM, Boxrud DJ, Hennessy TW, Bender JB, Henderson FA, Osterholm, MT. Limitations of pulsed-field gel electrophoresis for the routine surveillance of Campylobacter infections. [letter; comment.]. Journal of Infectious Diseases 2001; 184(2):242-244.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v184n2/010160/010160.html
142. Hedberg CW, Savarino SJ, Besser JM, Paulus CJ, Thelen VM, Myers LJ, Cameron DN, Barrett TJ, Kaper JB, Osterholm MT, and the Investigation Team. An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. Journal of Infectious Diseases 176(6):1625-8, 1997.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n6/de26_1610/de26_1610.
     web.pdf
143. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. [see comments.]. Archives of Internal Medicine 2000; 160(10):1399-1408.
144. Heimer R, Van Andel A, Wormser GP, Wilson ML. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. Journal of Clinical Microbiology 1997; 35(4):923-927.
     Open Access:http://jcm.asm.org/cgi/content/abstract/35/4/923?maxtoshow=&HITS=10&hits=10&
     RESULTFORMAT=&author1=heimer,+r&searchid=1062614128544_3899&stored_search=&FIRSTINDEX=
     0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
145. Heimer R, Tisdale D, Dawson JE. A single tissue culture system for the propagation of the agents of the human ehrlichioses.[comment]. American Journal of Tropical Medicine & Hygiene 1998; 58(6):812-815. Posted with permission from The American Society of Tropical Medicine and Hygiene. Download PDF [4 pages, 76 KB]
146. Hennessy TW, Hedberg CW, Slutsker L, White KE, Besser-Wiek JM, Moen ME et al. A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team.[see comment]. New England Journal of Medicine 334(20):1281-6, 1996.
147. Hennessy TW, Marcus R, Deneen V, Reddy S, Vugia D, Townes J, Bardsley M, Swerdlow D, Angulo FJ, and the Emerging Infections Program FoodNet Working Group . Survey of physician diagnostic practices for patients with acute diarrhea: clinical and public health implications. Clinical Infectious Diseases 2004; 38(Suppl 3):S203-211.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32115/32115.html
148. Hennessy TW, Cheng LH, Kassenborg H, Ahuja SD, Mohle-Boetani J, Marcus R, Shiferaw B, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Egg consumption is the principal risk factor for sporadic Salmonella serotype Heidelberg infections: a case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S237-243.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32119/32119.html
149. Henning KJ, Hall EL, Dwyer DM, Billmann L, Schuchat A, Johnson JA, Harrison LH, and the Maryland Emerging Infections Program. Invasive group B streptococcal disease in Maryland nursing home residents. Journal of Infectious Diseases 2001; 183(7):1138-1142.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v183n7/001100/001100.html
150. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiology & Infection 129(1):9-17, 2002.
     Reprinted with the permission of Cambridge University Press Download PDF [9 pages, 139 KB]
151. Hilborn ED, Mermin JH, Mshar PA, Hadler JL, Voetsch A, Wojtkunski C et al. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch Intern Med 1999; 159(15):1758-1764.
152. Hilborn ED, Mshar PA, Fiorentino TR, Dembek ZF, Barrett TJ, Howard RT et al. An outbreak of Escherichia coli O157:H7 infections and haemolytic uraemic syndrome associated with consumption of unpasteurized apple cider. Epidemiology & Infection 2000; 124(1):31-36.
     Reprinted with the permission of Cambridge University Press Download PDF [6 pages, 153 KB]
153. Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P et al. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nature Medicine 1999; 5(8):924-929.
154. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. [see comments.]. New England Journal of Medicine 1995; 333(8):481-486.
155. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infection & Immunity 70(4):2171-7, 2002.
     Open Access:http://iai.asm.org/cgi/content/full/70/4/2171
156. Huang C, Thompson WH, Karabatsos N, Grady L, Campbell WP. Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes. Virus Research 1997; 48(2):143-148. Reprinted from Virus Research, Vol. 48, Huang et al, Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes, ©2002, with permission from Elsevier.
     http://www.sciencedirect.com/science/journal/01681702 Download PDF [6 pages, 354 KB]
157. Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system. New England Journal of Medicine 1999; 340(6):483-484.
158. Huang C, Campbell W, Grady L, Kirouac I, LaForce FM. Diagnosis of Jamestown Canyon encephalitis by polymerase chain reaction. Clinical Infectious Diseases 1999; 28(6):1294-1297.
     Open access: http://www.journals.uchicago.edu/CID/journal/issues/v28n6/ju25_1294/ju25_1294.web.pdf
159. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001; 286(15):1857-1862.
160. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A et al. Trends in incidence and
     antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002; 110(4):690-695.

To Top




Bibliography by Author: I - M

161. Igwe EI, Shewmaker PL, Facklam RR, Farley MM, Van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiology Letters 2003; 229(2):259-264.
     Reprinted from FEMS Microbiology Letters, Vol. 229, Igwe et al., Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans., pgs 259-264, ©2003, with permission from Elsevier. For more information, visit Http://www.sciencedirect.com/science/journal/03781097 Download PDF [6 pages, 294 KB]
162. IJdo JW, Zhang Y, Hodzic E, Magnarelli LA, Wilson ML, Telford SR, III et al. The early humoral response in human granulocytic ehrlichiosis. Journal of Infectious Diseases 1997; 176(3):687-692.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n3/se50_687/se50_687.web.pdf
163. IJdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infection & Immunity 1998; 66(7):3264-3269.
     Open Access:http://iai.asm.org/cgi/content/full/66/7/3264?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=ijdo&searchid=1062612556634_1684&stored_search=&FIRSTINDEX=0&journalcode=iai
164. IJdo JW, Wu C, Magnarelli LA, Fikrig E. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 1999; 37(11):3540-3544.
     Open access: http://jcm.asm.org/cgi/content/full/37/11/3540?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT==&author1=magnarelli+la&searchid=1062614172122_3903&stored_search=&FIRSTINDEX=0&
     search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
165. IJdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, Fikrig E, Ryder RW. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. Journal of Infectious Diseases 2000; 181(4):1388-1393.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v181n4/991122/991122.html
166. Imhoff B, Morse D, Shiferaw B, Hawkins M, Vugia D, Lance-Parker S, Hadler J, Medus C, Kennedy M, Moore MR, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group . Burden of self-reported acute diarrheal illness in FoodNet surveillance areas, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S219-226.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32117/32117.html
167. Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. American Journal of Public Health 85(6):843-5, 1995.
168. Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD et al. Risk factors for group B streptococcal disease in adults. [see comments.]. Annals of Internal Medicine 1995; 123(6):415-420.
     Open Access:http://www.annals.org/cgi/content/full/123/6/415
169. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat.[see comment]. JAMA 273(5):383-9, 1995.
170. Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial. JAMA 1999; 282(7):646-650.
171. Jacoby D, St Louis T, Navarro V. Hepatitis C practice routines among Connecticut's naturopathic physicians. American Journal of Gastroenterology 2001; 96(9):2801-2802.
172. Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. American Journal of Public Health 1999; 89(3):364-368.
     Copyright held by APHA, posted with permission Download PDF [6 pages, 1000 KB]
173. Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infectious Diseases in Obstetrics & Gynecology 11(3):139-45, 2003.
174. Jones JL, Lopez A, Wahlquist SP, Nadle J, Wilson M, Emerging Infections Program FoodNet Working Group. Survey of clinical laboratory practices for parasitic diseases. Clinical Infectious Diseases 38 Suppl 3:S198-202, 2004.
     Open access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32114/32114.html
175. Jones TF. The Tennessee Foodborne Illness Surveillance Network (FoodNet). Tennessee Medicine 2000; 93(9):334-335.
     Republished with the permission of Tennessee Medical Association and Tennessee Medicine,
     ©2000 Download PDF [2 pages, 333 KB]
176. Jones TF, Gerber DE. Perceived etiology of foodborne illness among public health personnel. Emerg Infect Dis 2001; 7(5):904-905.
177. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An outbreak of community-acquired foodborne
     illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2002; 8(1):82-84.
178. Jones TF, Chaves SS, Barrett TJ, Moore MR. Epidemiology of bacterial enteric infections under active surveillance in Tennessee and Georgia, 2000-2002. Tenn Med 2004; 97(7):319-321.
     Republished with the permission of Tennessee Medical Association and Tennessee Medicine, ©2004
     Download PDF [3 pages, 686 KB]
179. Jones TF, Imhoff B, Samuel M, Mshar P, McCombs KG, Hawkins M, Deneen V, Cambridge M, Olsen SJ, for the Emerging Infections Program FoodNet Working Group . Limitations to successful investigation and reporting of foodborne outbreaks: an analysis of foodborne disease outbreaks in FoodNet catchment areas, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S297-302.
     Open access: http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32126/32126.html
180. Jones TF, Pavlin BI, LaFleur BJ, Ingram LA, Schaffner W. Restaurant inspection scores and foodborne
     disease. Emerg Infect Dis 2004; 10(4):688-692.
181. Jorgensen JH, Weigel LM, Swenson JM, Whitney CG, Ferraro MJ, Tenover FC. Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrobial Agents & Chemotherapy 2000; 44(11):2962-2968.
     Open access: http://aac.asm.org/cgi/content/full/44/11/2962?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=jorgensen,+jh&searchid=1062612215209_2025&stored_search=&FIRSTINDEX=0&
     search_url=http://aac.asm.org/cgi/search&journalcode=aac
182. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA . The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. [see comments.]. Clinical Infectious Diseases 1999; 29(5):1164-1170.
     Open access:http://www.journals.uchicago.edu/CID/journal/issues/v29n5/990148/990148.html
183. Karras DJ. Incidence of foodborne illnesses: preliminary data from the foodborne diseases active surveillance network (FoodNet). [Review] [26 refs]. Annals of Emergency Medicine 2000; 35(1):92-93.
     Reprinted from Annals Of Emergency Medicine, vol 35, Karras DJ, “Incidence of foodborne illnesses: preliminary data from the foodborne diseases active surveillance network (FoodNet)” p. 92-93, ©2000, with permission from the American College of Emergency Physicians.
184. Kassenborg HD, Hedberg CW, Hoekstra M, Evans MC, Chin AE, Marcus R, Vugia DJ, Smith K, Ahuja SD, Slutsker L, Griffin PM, for the Emerging Infections Program FoodNet Working Group . Farm visits and undercooked hamburgers as major risk factors for sporadic Escherichia coli O157:H7 infection: data from a case-control study in 5 FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S271-278.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32123/32123.html
185. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, Carter MA,  Dumas NB, Cassidy MP, Marano N, Tauxe RV, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clinical Infectious Diseases 2004; 38(Suppl 3):S279-284.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32124/32124.html
186. Kaufman SS, Chatterjee NK, Fuschino ME, Magid MS, Gordon RE, Morse DL et al. Calicivirus enteritis in an intestinal transplant recipient. American Journal of Transplantation 3(6):764-8, 2003.
187. Keene WE, Sazie E, Kok J, Rice DH, Hancock DD, Balan VK et al. An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 1997; 277(15):1229-1231.
188. Keene WE, Hedberg K, Herriott DE, Hancock DD, McKay RW, Barrett TJ, Fleming DW. A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk. Journal of Infectious Diseases 1997; 176(3):815-818.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n3/se29_755/se29_755.web.pdf
189. Keene WE. Lessons from investigations of foodborne disease outbreaks. JAMA 1999; 281(19):1845-1847.
190. Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T et al. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. Journal of Infectious Diseases 2002; 186(1):40-48.
     Open Access: http://www.journals.uchicago.edu/JID/journal/issues/v186n1/011437/011437.html
191. Kennedy M, Villar R, Vugia DJ, Rabatsky-Ehr T, Farley MM, Pass M et al. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S142-148.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32106/32106.html
192. Kimura AC, Reddy V, Marcus R, Cieslak PR, Mohle-Boetani JC, Kassenborg HD,  Segler SD, Hardnett FP, Barrett T, Swerdlow DL, for the Emerging Infections Program FoodNet Working Group . Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S244-252.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32120/32120.html
193. Kimura AC, Johnson K, Palumbo MS, Hopkins J, Boase JC, Reporter R et al. Multistate shigellosis outbreak and commercially prepared food, United States. Emerging Infectious Diseases 10(6):1147-9, 2004.
     Open Access:http://www.cdc.gov/ncidod/EID/vol10no6/03-0599.htm
194. King MD, Whitney CG, Parekh F, Farley MM, Active Bacterial Core Surveillance Team/Emerging Infections Program. Recurrent invasive pneumococcal disease: a population-based assessment. Clinical Infectious Diseases 2003; 37(8):1029-1036.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v37n8/31012/31012.html
195. Kluger MD, Sofair AN, Heye CJ, Meek JI, Sodhi RK, Hadler JL. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut. American Journal of Public Health 2001; 91(8):1214-1219.
     Copyright held by APHA, posted with permission Download PDF [6 pages, 169 KB]
196. Kupronis BA, Richards CL, Whitney CG, Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community.[see comment]. Journal of the American Geriatrics Society 2003; 51(11):1520-1525.
197. LaClaire LL, Tondella ML, Beall DS, Noble CA, Raghunathan PL, Rosenstein NE et al. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. Journal of Clinical Microbiology 41(1):393-6, 2003.
     Open Access:http://jcm.asm.org/cgi/content/full/41/1/393
198. Lance-Parker S, Rebmann C, Kramer S, Kelly R. Arboviruses in Georgia. Emergence of West Nile Virus. Journal of the Medical Association of Georgia 91(2):32-4, 2002.
199. Lee R, Beatty ME, Bogard AK, Esko MP, Angulo FJ, Selman C et al. Prevalence of high-risk egg-preparation practices in restaurants that prepare breakfast egg entrees: an EHS-Net study. J Food Prot 2004; 67(7):1444-1450. Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: MN Dept. of Health, CA Emerging Infections Program, CDC. Download PDF [7 pages, 69 KB]
200. Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive
     pneumococcal disease in children: a population-based case-control study in North America. [see comments.]. Pediatrics 1999; 103(3):E28.
201. Li Z, Sakota V, Jackson D, Franklin AR, Beall B, Active Bacterial Core Surveillance/Emerging Infections Program. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. Journal of Infectious Diseases 188(10):1587-92, 2003.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v188n10/30894/30894.html
202. Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA et al. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine 2001; 19(31):4566-4575.
     Reprinted from Vaccine, Vol 19, Lingappa et al., “Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States”, ©2001, p. 4566-4575, with permission from Elsevier. http://www.sciencedirect.com/science/journal/0264410X Download PDF [10 pages, 128 KB]
203. Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA et al. Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. Journal of Clinical Microbiology 2003; 41(3):1316-1321.
     Open Access: http://jcm.asm.org/cgi/content/full/41/3/1316?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&full
     text=1316&searchid=1122491040529_3815&stored_search=&FIRSTINDEX=0&volume=41&issue=3&search_
     url=http%3A%2F%2Fjcm.asm.org%2Fcgi%2Fsearch&journalcode=jcm
204. Louie JK, Hacker JK, Mark J, Gavali SS, Yagi S, Espinosa A et al. SARS and common viral infections. Emerging Infectious Diseases 10(6):1143-6, 2004.
205. Louie JK, Gavali SS, Belay ED, Trevejo R, Hammond LH, Schonberger LB et al. Barriers to Creutzfeldt-
     Jakob disease autopsies, California. Emerg Infect Dis 2004; 10(9):1677-1680.
206. Lu HZ, Bloch KC, Tang YW. Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep 2002; 4(4):339-350.
207. Lynch M, Lee B, Azimi P, Gentsch J, Glaser C, Gilliam S et al. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis 2001; 33(7):932-938.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n7/001586/001586.html
208. Lynfield R, Guerina NG. Toxoplasmosis. Pediatr Rev 1997; 18(3):75-83.
209. Lynfield R, Hsu HW, Guerina NG. Screening methods for congenital toxoplasma and risk of disease. [letter; comment.]. Lancet 1999; 353(9168):1899-1900.
     Reprinted with permission from Elsevier (The Lancet, 1999; 383(9168):1899-1900) For more information, visit
     http://www.sciencedirect.com/science/journal/01406736 Download PDF [2 pages, 62 KB]
210. Magnarelli LA, IJdo JW, Anderson JF, Padula SJ, Flavell RA, Fikrig E. Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. Journal of Clinical Microbiology 1998; 36(10):2823-2827.
     Open Access: http://jcm.asm.org/cgi/content/full/36/10/2823?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=magnarelli+la&searchid=1062614172122_3903&stored_search=&FIRSTINDEX=0&
     search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
211. Magnarelli LA, IJdo JW, Dumler JS, Heimer R, Fikrig E. Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. Journal of Infectious Diseases 1998; 178(6):1835-1838.
     Open access: http://www.journals.uchicago.edu/JID/journal/issues/v178n6/980461/980461.html
212. Magnarelli LA, Van Andel AE, IJdo JW, Heimer R, Fikrig E. Serologic testing of horses for granulocytic ehrlichiosis, using indirect fluorescent antibody staining and immunoblot analysis. American Journal of Veterinary Research 60(5):631-5, 1999.
213. Marcus R, Rabatsky-Ehr T, Mohle-Boetani JC, Farley M, Medus C, Shiferaw B et al. Dramatic decrease in the incidence of Salmonella serotype Enteritidis infections in 5 FoodNet sites: 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S135-141.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32105/32105.html
214. McCarthy TA, Barrett NL, Hadler JL, Salsbury B, Howard RT, Dingman DW et al.Hemolytic-Uremic
     Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999. Pediatrics 2001; 108(4):E59.
215. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.[comment]. Nature Medicine 2003; 9(4):424-430.
216. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. [see comments.]. New England Journal of Medicine 2001; 345(16):1155-1160.
217. McEllistrem MC, Stout JE, Harrison LH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. Journal of Clinical Microbiology 2000; 38(1):351-353.
     Open Access:http://jcm.asm.org/cgi/content/full/38/1/351?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=mcellistrem,+mc&searchid=1062614326762_3914&stored_search=&FIRSTINDEX=0&
     search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
218. McEllistrem MC, Pass M, Elliott JA, Whitney CG, Harrison LH. Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. Journal of Clinical Microbiology 2000; 38(12):4367-4372.
     Open access: http://jcm.asm.org/cgi/content/full/38/12/4367?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=mcellistrem,+mc&searchid=1062614326762_3914&stored_search=&FIRSTINDEX=0&
     search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
219. McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, Kolano JA, Harrison LH. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. Journal of Infectious Diseases 2002; 185(9):1364-1368.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v185n9/011115/011115.html
220. McEllistrem MC, Mendelsohn AB, Pass M, Elliott JA, Whitney CG, Albanese BA, Harrison LH. Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance. Clinical Infectious Diseases 2002; 34(5):704-707.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v34n5/010830/010830.html
221. McEllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. Journal of Infectious Diseases 188(11):1679-84, 2003.
     Open Access: http://www.journals.uchicago.edu/JID/journal/issues/v188n11/30794/30794.html
222. McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn AB, Fonseca Pacheco AG et al. Correlating
     epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerging Infectious Diseases 10(3):451-6, 2004.
223. McEllistrem MC, Noller AC, Visweswaran S, Adams JM, Harrison LH. Serotype 14 variants of the France 9V(-3) clone from Baltimore, Maryland, can be differentiated by the cpsB gene. Journal of Clinical Microbiology 42(1):250-6, 2004.
     Open Access:http://jcm.asm.org/cgi/content/full/42/1/250
224. McNeil MM, Sweat LB, Carter SL, Jr., Watson CB, Holloway JT, Manning R et al. A Mexican restaurant-associated outbreak of Salmonella Enteritidis type 34 infections traced to a contaminated egg farm. Epidemiology & Infection 122(2):209-15, 1999.
     Reprinted with permission from Cambridge University Press. Download PDF [7 pages, 220 KB]
225. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C et al.Food-related illness and death in the
     United States. [see comments.]. [Review] [107 refs]. Emerging Infectious Diseases 1999; 5(5):607-625.
226. Mead PS, Slutsker L, Griffin PM, Tauxe RV. Food-related illness and death in the united states reply to
     Dr. Hedberg. Emerging Infectious Diseases 5(6):841-842, 1999.
227. Meek JI, Roberts CL, Smith EV, Jr., Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. Journal of Public Health Management & Practice 2(4):61-5, 1996.
228. Meek J. West Nile virus in the United States. [Review] [35 refs]. Current Opinion in Pediatrics 2002; 14(1):72-77.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [7 pages, 713KB]
229. Mermin J, Hutwagner L, Vugia D, Shallow S, Daily P, Bender J, Koehler J, Marcus R, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clinical Infectious Diseases 2004; 38(Suppl 3):S253-261.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32121/32121.html
230. Metlay JP, Hofmann J, Cetron MS, Fine MJ, Farley MM, Whitney C, Breiman RF. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clinical Infectious Diseases 2000; 30(3):520-528.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n3/990974/990974.html
231. Moore KA, Osterholm MT. Meningococcal disease and public health practice: a complicated road map.[see comment][comment]. JAMA 279(6):472-3, 1998.
232. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. [Review] [72 refs]. The Lancet Infectious Diseases 3(4):201-13, 2003.
233. Morin CA , Roberts CL, Mshar PA, Addiss DG, Hadler JL. What do physicians know about cryptosporidiosis? A survey of Connecticut physicians. Archives of Internal Medicine 1997; 157(9):1017-1022.
234. Morin CA , Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. Journal of Infectious Diseases 2001; 184(8):1029-1034.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v184n8/010295/010295.html
235. Morita JY, Zell ER, Danila R, Farley MM, Hadler J, Harrison LH, Lefkowitz L, Reingold A, Kupronis BA, Schuchat A, and Whitney CG . Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clinical Infectious Diseases 2002; 35(4):420-427.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n4/010951/010951.html
236. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, Phelan M, Facklam RR, Cetron MS, Breiman RF, Kolczak M, Schuchat A. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clinical Infectious Diseases 2001; 33(6):797-805.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n6/001419/001419.html
237. Morotti RA, Kaufman SS, Fishbein TM, Chatterjee NK, Fuschino ME, Morse DL et al. Calicivirus infection in pediatric small intestine transplant recipients: pathological considerations. Human Pathology 35(10):1236-40, 2004.
238. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. Journal of Clinical Microbiology 42(1):320-8, 2004.
     Open Access:http://jcm.asm.org/cgi/content/full/42/1/320
239. Mukamel DB, Gold HT, Bennett NM. Cost utility of public clinics to increase pneumococcal vaccines in the elderly. American Journal of Preventive Medicine 21(1):29-34, 2001.
     Reprinted from American Journal of Preventive Medicine, Vol 21, Mukamel, et al., “Cost utility of public clinics to increase pneumococcal vaccines in the elderly” p. 39-34, ©2001, with permission from the American Journal of Preventive Medicine. Download PDF [6 pages, 176KB]
240. Mullen L, Barry J, Igoe D, Keenan E, Ward M, Murray K. Unexplained illness among injecting drug users in Dublin: a case-control study. Journal of Epidemiology & Community Health 2002; 56(8):575-576.
     Open Access:http://jech.bmjjournals.com/cgi/content/full/56/8/575

To Top




Bibliography by Author: N - R

241. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clinical Infectious Diseases 2001; 33(7):990-996.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n7/010122/010122.html
242. Naimi TS, Smith KE, Besser J, Lynfield R. Antimicrobial resistance and judicious antimicrobial use in Minnesota and the United States. Minnesota Medicine 2001; 84(4):27-31.
     Open Access: http://www.mnmed.org/publications/MnMed2001/April/Naimi.html
243. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.[see comment]. JAMA 290(22):2976-84, 2003.
244. Naimi TS, Anderson D, O'Boyle C, Boxrud DJ, Johnson SK, Tenover FC, Lynfield R. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clinical Infectious Diseases 36(12):1609-12, 2003.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v36n12/30400/30400.html
245. Naimi TS, Wicklund JH, Olsen SJ, Krause G, Wells JG, Bartkus JM et al. Concurrent outbreaks of Shigella sonnei and enterotoxigenic Escherichia coli infections associated with parsley: implications for surveillance and control of foodborne illness. Journal of Food Protection 66(4):535-41, 2003.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: MN Dept. of Health, CDC. Download PDF [7 pages, 351KB]
246. Navarro VJ, St Louis T, Bell BZ, Sofair AN. Chronic liver disease in the primary care practices of Waterbury, Connecticut. Hepatology 2003; 38(4):1062.
     Open Access:http://www3.interscience.wiley.com/cgi-bin/abstract/106596004/ABSTRACT
247. Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. Journal of Clinical Gastroenterology 2003; 36(5):431-435.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 332KB]
248. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. Journal of Infectious Diseases 2004;(6):1150-1157.
249. Nikkari S, Lopez FA, Lepp PW, Cieslak PR, Ladd-Wilson S, Passaro D et al.Broad-range bacterial detection
     and the analysis of unexplained death and critical illness. Emerging Infectious Diseases 8(2):188-94, 2002.
250. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE et al. Genetic locus for streptolysin S production by group A streptococcus. Infection & Immunity 68(7):4245-54, 2000.
     Open Access: http://iai.asm.org/cgi/content/full/68/7/4245
251. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. [see comments.]. New England Journal of Medicine 2000; 342(10):681-689.
252. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. [see comments.]. Annals of Internal Medicine 2000; 132(3):182-190.
     Open Access:http://www.annals.org/cgi/content/full/132/3/182
253. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A, for the Active Bacterial Core Surveillance/Emerging Infections Program Network . Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clinical Infectious Diseases 2002; 35(3):268-276.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n3/020056/020056.html
254. Ogunmodede F, Virnig BA, Danila R, Lynfield R. Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelines. Minnesota Medicine 86(8):40-5, 2003.
     Open Access:http://www.mmaonline.net/publications/MNMed2003/August/Lynfield.html
255. Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S et al. A nosocomial outbreak of fluoroquinolone-resistant salmonella infection. New England Journal of Medicine 2001; 344(21):1572-1579.
256. Parashar UD, Chung MA, Holman RC, Ryder RW, Hadler JL, Glass RI. Use of state hospital discharge data
     to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus
     immunization program: A pilot study in Connecticut. Pediatrics 104(3 Pt 1):489-94, 1999.
257. Park SY, Glaser C, Murray WJ, Kazacos KR, Rowley HA, Fredrick DRet al.Raccoon roundworm
     (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics 2000; 106(4):E56.
258. Passaro DJ, Shieh WJ, Hacker JK, Fritz CL, Hogan SR, Fischer M et al. Predominant kidney involvement in a fatal case of hantavirus pulmonary syndrome caused by Sin Nombre virus. Clin Infect Dis 2001; 33(2):263-264. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n2/001329/001329.html
259. Passaro DJ, Smitht DS, Hett EC, Reingold AL, Daily P, Van Beneden CA et al. Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiology & Infection 2002; 129(3):471-478. Reprinted with the permission of Cambridge University Press. Download PDF [8 pages, 159KB]
260. Perkins BA, Flood JM, Danila R, Holman RC, Reingold AL, Klug LA et al.Unexplained deaths due to possibly
     infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. Emerging Infectious Diseases 1996; 2(1):47-53.
261. Perkins BA, Relman D. Explaining the unexplained in clinical infectious diseases: looking forward. Emerging Infectious Diseases 1998; 4(3):395-397.
262. Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagnostic Microbiology & Infectious Disease 1999; 33(4):217-222.
263. Pinner RW. Addressing the challenges of emerging infectious disease. [Review] [23 refs]. American Journal of the Medical Sciences 1996; 311(1):3-8. Posted with permission from Lippincott, Williams & Wilkins.
264. Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and
     public health communities. Emerg Infect Dis 2003; 9(7): 781-787.
265. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 2004; 48(9):3491-3497.
     Open Access:http://aac.asm.org/cgi/content/full/48/9/3491
266. Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. Journal of Clinical Microbiology 2001; 39(1):75-85. Open Access:http://jcm.asm.org/cgi/content/full/39/1/75?maxtoshow=&HITS
     =10&hits=10&RESULTFORMAT=&author1=popovic,+t&author2=rosenstein+na&searchid=1062614588818_
     3954&stored_search=&FIRSTINDEX=0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
267. Price NO, Hacker JK, Silvers JH, Crawford-Miksza L, Hendry RM, Flood J et al. Adenovirus type 3 viremia in an adult with toxic shock-like syndrome.[comment]. Clin Infect Dis 2001; 33(2):260-262.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n2/001246/001246.html
268. Rabatsky-Ehr T, Dingman D, Marcus R, Howard R, Kinney A, Mshar P. Deer meat as the source for a
     poradic case of Escherichia coli O157:H7 infection, Connecticut. Emerging Infectious Diseases 2002; 8(5):525-527.
269. Rabatsky-Ehr T, Whichard J, Rossiter S, Holland B, Stamey K, Headrick ML et al. Multidrug-resistant
     strains of Salmonella enterica Typhimurium, United States, 1997-1998. Emerging Infectious Diseases 10(5):795-801, 2004.
270. Raghunathan PL, Bernhardt SA, Rosenstein NE. Opportunities for control of meningococcal disease in the United States. [Review] [138 refs]. Annual Review of Medicine 55:333-53, 2004.
     Reprinted, with permission, from the Annual Review of Medicine, Volume 55, ©2004 by Annual Reviews
     www.annualreviews.org Download PDF [23 pages, 245KB]
271. Rainbow J, Lynfield R, Johnson JR, Danila RN. Minnesota surveillance for unexplained deaths and critical illnesses of possible infectious cause. Minnesota Medicine 2000; 83(1):51-53.
     Open Access:http://www.mnmed.org/publications/MnMed2000/January/Rainbow.cfm
272. Ray SM, Ahuja SD, Blake PA, Farley MM, Samuel M, Fiorentino T et al. Population-based surveillance for Yersinia enterocolitica infections in FoodNet sites, 1996-1999: higher risk of disease in infants and minority populations. Clinical Infectious Diseases 2004; 38(Suppl 3):S181-189.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32112/32112.html
273. Raymond NJ, Reeves M, Ajello G, Baughman W, Gheesling LL, Carlone GM, Wenger JD, Stephens DS. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. Journal of Infectious Diseases 1997; 176(5):1277-1284.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n5/no21_1277/no21_1277.web.
     pdf
274. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. [see comments.]. Clinical Infectious Diseases 1998; 27(5):1138-1147.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n5/no06_1138/no06_1138.web.
     pdf
275. Rees JR, Pannier MA, McNees A, Shallow S, Angulo FJ, Vugia DJ. Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S311-317.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32130/32130.html
276. Reeves MW, Perkins BA, Wenger JD. Epidemic-associated Neisseria meningitidis detected by multilocus
     enzyme electrophoresis. Emerg Infect Dis 1995; 1(2):53-54.
277. Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial-resistant shigellosis in Oregon. Clinical Infectious Diseases 2000; 30(3):515-519.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n3/990964/990964.html
278. Roberts CL, Morin C, Addiss DG, Wahlquist SP, Mshar PA, Hadler JL. Factors influencing Cryptosporidium testing in Connecticut. Journal of Clinical Microbiology 1996; 34(9):2292-2293.
     Open access: http://jcm.asm.org/cgi/content/abstract/34/9/2292?maxtoshow=&HITS=10&hits=10&
     RESULTFORMAT=&author1=roberts,+c&searchid=1062614061589_3889&stored_search=&FIRSTINDEX=
     0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
279. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285(13):1729-1735.
280. Robinson KA, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C, et al. Risk for severe group A
     streptococcal disease among patients' household contacts. Emerg Infect Dis 2003; 9(4):443-447.
281. Rosenberg J, Jarvis WR, Abbott SL, Vugia DJ, California Emerging Infections Program. Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infection Control & Hospital Epidemiology 25(5):408-12, 2004.
282. Rosenstein NE , Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstetrics & Gynecology 1997; 90(6):901-906.
     Posted with permission of Lippincott, Williams & Wilkins. Download PDF [6 pages, 552KB]
283. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL, and the Active Bacterial Core Surveillance Team . The changing epidemiology of meningococcal disease in the United States, 1992-1996. Journal of Infectious Diseases 1999; 180(6):1894-1901.
     Open access:http://www.journals.uchicago.edu/JID/journal/issues/v180n6/990671/990671.html
284. Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Clinical Infectious Diseases 2000; 30(1):212-213.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n1/990425/990425.html
285. Rowe SY, Rocourt JR, Shiferaw B, Kassenborg HD, Segler SD, Marcus R, Daily PJ, Hardnett FP, Slutsker L, for the Emerging Infections Program FoodNet Working Group . Breast-feeding decreases the risk of sporadic salmonellosis among infants in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S262-270.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32122/32122.html
286. Roy SL, DeLong SM, Stenzel SA, Shiferaw B, Roberts JM, Khalakdina A et al. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. Journal of Clinical Microbiology 42(7):2944-51, 2004.
     Open Access:http://jcm.asm.org/cgi/content/full/42/7/2944

To Top




Bibliography by Author: S - Z

287. Sacchi CT, Whitney AM, Popovic T, Beall DS, Reeves MW, Plikaytis BD,  Rosenstein NE, Perkins BA,Tondella ML, Mayer LW . Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000; 182(4):1169-1176.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v182n4/000497/000497.html
288. Samuel MC, Portnoy D, Tauxe RV, Angulo FJ, Vugia DJ. Complaints of foodborne illness in San Francisco, California, 1998. Journal of Food Protection 2001; 64(8):1261-1264.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: California Emerging Infections Program and Dept. of Health Services, San Francisco Dept. of Public Health, CDC. Download PDF [4 pages, 941KB]
289. Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S165-174.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32110/32110.html
290. Satola SW, Schirmer PL, Farley MM. Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infection & Immunity 71(12):7202-7, 2003.
     Open Access: http://iai.asm.org/cgi/content/full/71/12/7202
291. Satola SW, Schirmer PL, Farley MM. Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infection & Immunity 71(6):3639-44, 2003.
     Open Access:http://iai.asm.org/cgi/content/full/71/6/3639
292. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity & Mortality Weekly Report Recommendations & Reports 51(RR-11):1-22, 2002.
293. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. [Review] [57 refs]. Infection Control & Hospital Epidemiology 2000; 21(7):473-483.
294. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. [see comments.]. New England Journal of Medicine 2000; 342(1):15-20.
295. Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: a reliable way to track antibiotic
     resistance in communities? Emerging Infectious Diseases 2002; 8(5):496-502.
296. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. [see comments.]. New England Journal of Medicine 2002; 347(4):233-239.
297. Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstetrics & Gynecology 102(4):753-60, 2003.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [8 pages, 102KB]
298. Schrag SJ, McGee L, Whitney CG, Beall B, Craig AS, Choate ME et al. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother 2004; 48(8):3016-3023.
     Open Access:http://aac.asm.org/cgi/content/full/48/8/3016
299. Schuchat A. Guidelines for prevention of perinatal group B streptococcal disease. Hmo Practice 1996; 10(4):190-191.
300. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. New England Journal of Medicine 1997; 337(14):970-976.
301. Schuchat A. Neonatal group B streptococcal disease--screening and prevention. [letter; comment.]. New England Journal of Medicine 2000; 343(3):209-210.
302. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L et al.Active bacterial core surveillance of
     the emerging infections program network. Emerg Infect Dis 2001; 7(1):92-99.
303. Schuchat A, Hillier S, Edwards K, Schrag S, Labbok M. Early opportunities for prevention: infections of
     pregnant women and young infants. Emerging Infectious Diseases 2001; 7(3:Suppl):Suppl.
304. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clinical Infectious Diseases 2001; 33(6):751-756. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n6/010158/010158.html
305. Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O'Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal & Child Health Journal 6(2):107-14, 2002.
     Reprinted with permission from the Maternal & Child Health Journal. For more information, visit www.wkap.nl/journalhome.htm/1092-7875 Download PDF [8 pages, 61KB]
306. Schuster FL , Dunnebacke TH, Booton GC, Yagi S, Kohlmeier CK, Glaser C et al. Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. Journal of Clinical Microbiology 41(7):3175-80, 2003.
     Open Access:http://jcm.asm.org/cgi/content/full/41/7/3175
307. Schuster FL , Glaser C, Honarmand S, Maguire JH, Visvesvara GS. Balamuthia amebic encephalitis risk,
     Hispanic Americans. Emerging Infectious Diseases 10(8):1510-2, 2004.
308. Schuster FL , Glaser C, Gilliam S, Visvesvara GS. Survey of sera from encephalitis patients for Balamuthia mandrillaris antibody. Journal of Eukaryotic Microbiology Suppl:10S-12S, 2001.
309. Shepard CW, Rosenstein NE, Fischer M, Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990 to 1999. Pediatric Infectious Disease Journal 2003; 22(5):418-422. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 109KB]
310. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, Patel JB et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clinical Infectious Diseases 2004; 38(6):799-804. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38n6/31850/31850.html
311. Shevlin JD, Summers-Bean C, Thomas D, Whitney CG, Todd D, Ray SM. A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospital. American Journal of Preventive Medicine 2002; 22(2):92-97.
     Reprinted from the American Journal of Preventative Medicine, vol. 22, Shevlin et al., A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospital, pgs. 92-97, ©2002, with permission from the American Journal of Preventative Medicine. Download PDF [6 pages, 73KB]
312. Shiferaw B, Yang S, Cieslak P, Vugia D, Marcus R, Koehler J et al. Prevalence of high-risk food consumption and food-handling practices among adults: a multistate survey, 1996 to 1997. The Foodnet Working Group. Journal of Food Protection 2000; 63(11):1538-1543.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: CA State Health Division, OR Health Division, Yale University, GA Div. of Public Health, MN Dept. of Public Health, CDC. Download PDF [6 pages, 461KB]
313. Shiferaw B, Shallow S, Marcus R, Segler S, Soderlund D, Hardnett FP, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group . Trends in population-based active surveillance for shigellosis and demographic variability in FoodNet sites, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S175-180.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32111/32111.html
314. Slavin KA, Passaro DJ, Hacker JK, Hendry RM, Kohl S. Parainfluenza virus type 4: case report and review of the literature. [Review] [10 refs]. Pediatr Infect Dis J 2000; 19(9):893-896.
     Reprinted with permission from Lippincott, Williams & Wilkins.
315. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. [see comments.]. New England Journal of Medicine 1999; 340(20):1525-1532.
316. Smith KE, Stenzel SA, Bender JB, Wagstrom E, Soderlund D, Leano FT et al. Outbreaks of enteric infections caused by multiple pathogens associated with calves at a farm day camp. Pediatr Infect Dis J 2004; 23(12):1098-1104. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [7 pages, 382KB]
317. Stefonek KR, Maerz LL, Nielsen MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. [see comments.]. Obstetrics & Gynecology 2001; 98(5:Pt 1):846-848.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [3 pages, 82KB]
318. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Annals of Internal Medicine 1995; 123(12):937-940. Open Access:http://www.annals.org/cgi/content/full/123/12/937
319. Stephens DS, Moxon ER, Adams J, Altizer S, Antonovics J, Aral S et al. Emerging and reemerging infectious diseases: a multidisciplinary perspective. Am J Med Sci 1998; 315(2):64-75.
     Posted with permission. Copyright held by Lippincott, Williams & Wilkins.
320. Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, Gay K et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365(9462):855-63, 2005.
321. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 1997; 94(1):271-276.
     Open Access:http://www.pnas.org/cgi/content/full/94/1/271?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=1&author1=swartley&searchid=1062615508300_20368&stored_search=&FIRSTINDEX=0&sort
     spec=relevance
322. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J 2004; 23(8):726-731.
     Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 590KB]
323. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. American Journal of Medicine 118(3):285-91, 2005.
324. Tappero JW, Schuchat A, Deaver KA, Mascola L, Wenger JD. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA 1995; 273(14):1118-1122.
325. The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002; 35(8):950-959.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n8/020374/020374.html
326. Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment. Infect Control Hosp Epidemiol 2002; 23(11):683-688.
327. Tondella ML, Popovic T, Rosenstein NE, Lake DB, Carlone GM, Mayer LW et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. Journal of Clinical Microbiology 2000; 38(9):3323-3328. Open Access:http://jcm.asm.org/cgi/content/full/38/9/3323?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=
     &author1=tondella,+ml&searchid=1062614442508_3929&stored_search=&FIRSTINDEX=0&search_url=http://
     jcm.asm.org/cgi/search&journalcode=jcm
328. Townes JM, Hoffmann CJ, Kohn MA. Neurocysticercosis in Oregon, 1995-2000. Emerging Infectious Diseases 10(3):508-10, 2004.
329. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. [see comments.]. Clinical Infectious Diseases 1996; 22(6):1069-1076.
330. Van Andel AE, Magnarelli LA, Heimer R, Wilson ML. Development and duration of antibody response against Ehrlichia equi in horses. J Am Vet Med Assoc 1998; 212(12):1910-1914.
331. Van Beneden CA, Keene WE, Strang RA, Werker DH, King AS, Mahon B et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999; 281(2):158-162.
332. Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, et al.Aggregated antibiograms
     and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 2003; 9(9): 1089-1095.
333. Vanden Eng J, Marcus R, Hadler JL, Imhoff B, Vugia DJ, Cieslak P, et al.Consumer attitudes and inappropriate
     use of antibiotics. Emerg Infect Dis 2003;9(9):1128-1135.
334. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al. Community-acquired
     methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide
     emergence. Emerging Infectious Diseases 9(8):978-84, 2003.
335. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005; 191(4):554-561.
336. Virata M, Rosenstein NE, Hadler JL, Barrett NL, Tondella ML, Mayer LW et al. Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection. Clinical Infectious Diseases 27(5):1238-40, 1998. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n5/no23_1238/no23_1238.web.pdf
337. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clinical Infectious Diseases 2004; 38(Suppl 3):S127-134.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32104/32104.html
338. Voetsch AC, Angulo FJ, Rabatsky-Ehr T, Shallow S, Cassidy M, Thomas SM et al. Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000. Clinical Infectious Diseases 2004; 38(Suppl 3):S190-197.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32113/32113.html
339. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S et al. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clinical Infectious Diseases 2004; 38(Suppl 3):S149-156.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32107/32107.html
340. Wallace DJ, Van Gilder T, Shallow S, Fiorentino T, Segler SD, Smith KE et al. Incidence of foodborne illnesses reported by the foodborne diseases active surveillance network (FoodNet)-1997. FoodNet Working Group. J Food Prot 2000; 63(6):807-809.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: Emerging Infections Programs in CA, CT, GA; OR Health Division; MN Dept. of Health; US Dept. of Agriculture; Food and Drug Administration; CDC. Download PDF [3 pages, 277KB]
341. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clinical Infectious Diseases 2002; 34(8):1154-1157.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v34n8/011216/011216.html
342. Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. Journal of Infectious Diseases 2005;(2):234-237.
343. Weitkamp JH, Spring MD, Brogan T, Moses H, Bloch KC, Wright PF. Influenza A virus-associated acute necrotizing encephalopathy in the United States. Pediatric Infectious Disease Journal 2004; 23(3):259-263.
     Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 792KB]
344. Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. Journal of Infectious Diseases 1998; 178(2):569-572.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v178n2/au49_526/au49_526.web.pdf
345. Whitney CG, Plikaytis BD, Gozansky WS, Wenger JD, Schuchat A. Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group. Obstetrics & Gynecology 1997; 89(1):28-32.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 446KB]
346. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. [see comments.]. New England Journal of Medicine 2000; 343(26):1917-1924.
347. Whitney CG, Schaffner W, Butler JC. Rethinking recommendations for use of pneumococcal vaccines in adults. [Review] [123 refs]. Clinical Infectious Diseases 2001; 33(5):662-675.
     Open access: http://www.journals.uchicago.edu/CID/journal/issues/v33n5/001755/001755.html
348. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.[comment]. New England Journal of Medicine 2003; 348(18):1737-1746.
349. Williams LK, Reichert A, MacKenzie WR, Hightower AW, Blake PA. Lice, nits, and school policy. Pediatrics 2001; 107(5):1011-1015.
350. Winquist AG, Roome A, Mshar R, Fiorentino T, Mshar P, Hadler J. Outbreak of campylobacteriosis at a senior center. Journal of the American Geriatrics Society 2001; 49(3):304-307.
351. Wong S, Marcus R, Hawkins M, Shallow S, McCombs KG, Swanson E, Anderson B, Shiferaw B, Garman R, Noonan K, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group. Physicians as food-safety educators: a practices and perceptions survey. Clinical Infectious Diseases 2004; 38(Suppl 3):S212-218.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32116/32116.html
352. Working Group on Prevention of Invasive Group A Streptococcal Infections. Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections.[comment]. [Review] [49 refs]. JAMA 1998; 279(15):1206-1210.
353. Yang S. FoodNet and Enter-net: emerging surveillance programs for foodborne diseases. Emerging Infectious Diseases 1998; 4(3):457-458.
354. York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. Journal of Clinical Microbiology 37(6):1727-31, 1999.
     Open Access:http://jcm.asm.org/cgi/content/full/37/6/1727
355. Yusuf HR, Rochat RW, Baughman WS, Gargiullo PM, Perkins BA, Brantley MD et al. Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. American Journal of Public Health 1999; 89(5):712-717.
     Copyright held by APHA, posted with permission Download PDF [6 pages, 564KB]
356. Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW et al. School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. JAMA 1997; 277(5):389-395.
357. Zhao T, Doyle MP, Zhao P, Blake P, Wu FM. Chlorine inactivation of Escherichia coli O157:H7 in water. Journal of Food Protection 64(10):1607-9, 2001.
     Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: University of Georgia, GA State Public Health Dept.
     Download PDF [3 pages, 95KB]
358. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clinical Infectious Diseases 1998; 27(1):150-157.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n1/jy42_150/jy42_150.web.pdf

To Top

Bibliography by Activity: Active Bacterial Core Surveillance (ABCs)

1. Brandt ME, Hutwagner LC, Kuykendall RJ, Pinner RW. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance Group. Journal of Clinical Microbiology 1995; 33(7):1890-1895.
   Open access: http://jcm.asm.org/cgi/content/abstract/33/7/1890?maxtoshow=&HITS=10&hits=10&
   RESULTFORMAT=&author1=brandt,+me&searchid=1062612714885_3819&stored_search=&FIRSTINDEX=
   0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
2. Harrison LH, Ali A, Dwyer DM, Libonati JP, Reeves MW, Elliott JA et al. Relapsing invasive group B streptococcal infection in adults. [see comments.]. Annals of Internal Medicine 1995; 123(6):421-427.
   Open Access: http://www.annals.org/cgi/content/full/123/6/421
3. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. [see comments.]. New England Journal of Medicine 1995; 333(8):481-486.
4. Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD et al. Risk factors for group B streptococcal disease in adults. [see comments.]. Annals of Internal Medicine 1995; 123(6):415-420.
   Open Access: http://www.annals.org/cgi/content/full/123/6/415
5. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Annals of Internal Medicine 1995; 123(12):937-940.
   Open Access: http://www.annals.org/cgi/content/full/123/12/937
6. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a
   public health perspective. Centers for Disease Control and Prevention. [erratum appears in MMWR Morb Mortal Wkly Rep 1996 Aug 9;45(31):679.]. MMWR - Morbidity & Mortality Weekly Report 1996; 45(RR-7):1-24.
7. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b
   disease among infants and children--United States, 1993-1994. MMWR Morb Mortal Wkly Rep 1995; 44(29):545-550.
8. Reeves MW, Perkins BA, Wenger JD. Epidemic-associated Neisseria meningitidis detected by multilocus
   enzyme electrophoresis. Emerg Infect Dis 1995; 1(2):53-54.
   Tappero JW, Schuchat A, Deaver KA, Mascola L, Wenger JD. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA 1995; 273(14):1118-1122.
9. Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. American Journal of Public Health 85(6):843-5, 1995.
10. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat.[see comment]. JAMA 273(5):383-9, 1995.
11. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology 1996; 34(4):953-958.
    Open access: http://jcm.asm.org/cgi/content/abstract/34/4/953?maxtoshow=&HITS=10&hits=10&
    RESULTFORMAT=&author1=beall,+b&searchid=1062613942902_3880&stored_search=&FIRSTINDEX=10
    &search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
12. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. Journal of Clinical Microbiology 1996; 34(4):953-958.
    Open Access: http://jcm.asm.org/cgi/content/abstract/34/4/953?maxtoshow=&HITS=10&hits=10&
    RESULTFORMAT=&author1=beall%2C+b&searchid=1062613942902_3880&stored_search=&FIRSTINDEX=
    10&search_
    url=http%3A%2F%2Fjcm.asm.org%2Fcgi%2Fsearch&journalcode=jcm
13. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR et al. Invasive group B streptococcal disease: the emergence of serotype V. Journal of Infectious Diseases 1996; 173(2):365-373.
14. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EA et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. Journal of Clinical Microbiology 1996; 34(4):912-917.
    Open access: http://jcm.asm.org/cgi/content/abstract/34/4/912?maxtoshow=&HITS=10&hits=10&
    RESULTFORMAT=&author1=brandt,+me&searchid=1062612714885_3819&stored_search=&FIRSTINDEX
    =0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
15. Brandt ME, Pfaller MA, Hajjeh RA, Graviss EA, Rees J, Spitzer ED et al. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group. Journal of Infectious Diseases 1996; 174(4):812-820.
16. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. Journal of Infectious Diseases 1996; 174(5):986-993.
17. Schuchat A. Guidelines for prevention of perinatal group B streptococcal disease. Hmo Practice 1996; 10(4):190-191.
18. Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. [see comments.]. Clinical Infectious Diseases 1996; 22(6):1069-1076.
19. Centers for Disease Control and Prevention. Assessment of national reporting of drug-resistant
    Streptococcus =pneumoniae--United States, 1995-1996. MMWR Morb Mortal Wkly Rep 1996; 45(43):947-949.
20. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b
    disease among infants and children--United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996; 45(42):901-906.
21. Centers for Disease Control and Prevention. Serogroup Y meningococcal disease--Illinois,
    Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep 1996; 45(46):1010-1013.
22. Beall B, Facklam R, Hoenes T, Schwartz B. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. Journal of Clinical Microbiology 1997; 35(5):1231-1235. Open Access:http://jcm.asm.org/cgi/content/abstract/35/5/
    1231?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=
    &author1=beall,+b&searchid=1062613942902_3880&stored_search=&FIRSTINDEX=10&search_url=
    http://jcm.asm.org/cgi/search&journalcode=jcm
23. Fiorentino TR, Beall B, Mshar P, Bessen DE. A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. Journal of Infectious Diseases 1997; 176(1):177-182.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n1/jy21_177/jy21_177.web.pdf
24. Halsey NA, Schuchat A, Oh W, Baker CJ. The 1997 AAP guidelines for prevention of early-onset group
    B streptococcal disease. American Academy of Pediatrics. [see comments.]. Pediatrics 1997; 100(3):383-384.
25. Raymond NJ, Reeves M, Ajello G, Baughman W, Gheesling LL, Carlone GM et al. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. Journal of Infectious Diseases 1997; 176(5):1277-1284.
    open access: http://www.journals.uchicago.edu/JID/journal/issues/v176n5/no21_1277/no21_
    1277.web.pdf
26. Rosenstein NE , Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group. Obstetrics & Gynecology 1997; 90(6):901-906.
    Posted with permission of Lippincott, Williams & Wilkins. Download PDF [6 pages, 552KB]
27. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. New England Journal of Medicine 1997; 337(14):970-976.
28. Whitney CG, Plikaytis BD, Gozansky WS, Wenger JD, Schuchat A. Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group. Obstetrics & Gynecology 1997; 89(1):28-32.
    Posted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 446KB]
29. Centers for Disease Control and Prevention. Decreasing incidence of perinatal Group B streptococcal
    disease--United States, 1993-1995. MMWR Morb Mortal Wkly Rep 1997; 46(21):473-477.
30. Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW et al. School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. JAMA 1997; 277(5):389-395.
31. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 1997; 94(1):271-276.
    Open access: http://www.pnas.org/cgi/content/full/94/1/271?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=1&author1=swartley&searchid=1062615508300_20368&stored_search=&FIRSTINDEX=0&sort
    spec=relevance
32. Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatric Infectious Disease Journal 1997; 16(10):979-983.
    Reprinted with permission from Lippincott, Williams & Wilkins. [fischer-1997-tobacco smoke and mening.html]
33. Beall B, Facklam RR, Elliott JA, Franklin AR, Hoenes T, Jackson D et al. Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. Journal of Medical Microbiology 1998; 47(10):893-898.
    Posted with permission from the International Union of Microbiological Societies. Download PDF [8 pages, 922 KB]
34. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive
    disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood
    disease. Emerging Infectious Diseases 1998; 4(2):229-237.
35. Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, Cetron MS. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. American Journal of Epidemiology 1998; 148(12):1212-1218.
36. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. Journal of Infectious Diseases 1998; 177(4):998-1002.
    open access: http://www.journals.uchicago.edu/JID/journal/issues/v177n4/ap46_998/ap46_998.web.pdf
37. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. [see comments.]. Clinical Infectious Diseases 1998; 27(5):1138-1147.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n5/no06_1138/no06_1138.web.pdf
38. Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. Journal of Infectious Diseases 1998; 178(2):569-572.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v178n2/au49_526/au49_526.web.pdf
39. Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam R, Schwartz B et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clinical Infectious Diseases 1998; 27(1):150-157.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n1/jy42_150/jy42_150.web.pdf
40. Working Group on Prevention of Invasive Group A Streptococcal Infections. Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections.[comment]. [Review] [49 refs]. JAMA 1998; 279(15):1206-1210.
41. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal
    group B streptococcal disease--United States, 1997. MMWR Morb Mortal Wkly Rep 1998; 47(32):665-670.
42. Centers for Disease Control and Prevention. Haemophilus influenzae invasive disease among children aged
    <5 years--California, 1990-1996. MMWR - Morbidity & Mortality Weekly Report 1998; 47(35):737-740.
43. Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129(9):698-704.
    Open Access: http://www.annals.org/cgi/content/full/129/9/698
44. Moore KA, Osterholm MT. Meningococcal disease and public health practice: a complicated road map.[see comment][comment]. JAMA 279(6):472-3, 1998.
45. Centers for Disease Control and Prevention. Laboratory practices for prenatal Group B streptococcal
    screening and reporting--Connecticut, Georgia, and Minnesota, 1997-1998. MMWR Morb Mortal Wkly Rep 1999; 48(20):426-428.
46. Centers for Disease Control and Prevention. Geographic variation in penicillin resistance in
    Streptococcus pneumoniae--selected sites, United States, 1997. MMWR - Morbidity & Mortality Weekly Report 1999; 48(30):656-661.
47. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW. Tracking drug-resistant
    Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerging Infectious Diseases 1999; 5(5):688-693.
48. Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. [see comments.]. JAMA 1999; 281(16):1493-1497.
49. Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, E,Pappas, PG, Thomas C, Reingold, A, Rothrick, G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW, and the Cryptococcal Active Surveillance Group. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. [see comments.]. Journal of Infectious Diseases 1999; 179(2):449-454.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v179n2/980816/980816.html
50. Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. [erratum appears in JAMA 2000 May 24-31;283(20):2659.]. JAMA 1999; 281(20):1906-1910.
51. Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P et al. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nature Medicine 1999; 5(8):924-929.
52. Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial. JAMA 1999; 282(7):646-650.
53. Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. American Journal of Public Health 1999; 89(3):364-368.
    Copyright held by APHA, posted with permission Download PDF [6 pages, 1000 KB]
54. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA . The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. [see comments.]. Clinical Infectious Diseases 1999; 29(5):1164-1170.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v29n5/990148/990148.html
55. Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive
    pneumococcal disease in children: a population-based case-control study in North America. [see comments.]. Pediatrics 1999; 103(3):E28.
56. Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagnostic Microbiology & Infectious Disease 1999; 33(4):217-222.
57. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. Journal of Infectious Diseases 1999; 180(6):1894-1901.
58. Yusuf HR, Rochat RW, Baughman WS, Gargiullo PM, Perkins BA, Brantley MD et al. Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. American Journal of Public Health 1999; 89(5):712-717.
59. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E et al. emm typing and validation of
    provisional M types for group A streptococci. Emerging Infectious Diseases 5(2):247-53, 1999.
60. York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. Journal of Clinical Microbiology 37(6):1727-31, 1999.
    Open Access: http://jcm.asm.org/cgi/content/full/37/6/1727
61. Centers for Disease Control and Prevention. Laboratory capacity to detect antimicrobial resistance,
    1998. MMWR Morb Mortal Wkly Rep 2000; 48(51-52):1167-1171.
62. Centers for Disease Control and Prevention. Hospital-based policies for prevention perinatal Group B
    streptococcal disease--United States, 1999. [erratum appears in MMWR Morb Mortal Wkly Rep 2000 Oct 27;49(42):966.]. MMWR - Morbidity & Mortality Weekly Report 2000; 49(41):936-940.
63. Beall B, Gherardi G, Lovgren M, Facklam RR, Forwick BA, Tyrrell GJ. emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 2000; 146(Pt 5):1195-1209. Open Access: http://mic.sgmjournals.org/cgi/content/full/146/5/1195?view=long&pmid=10832648
64. Brandt ME, Harrison LH, Pass M, Sofair AN, Huie S, Li RK et al.Candida dubliniensis fungemia: the first
    four cases in North America. Emerging Infectious Diseases 2000; 6(1):46-49.
65. Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Archives of Internal Medicine 2000; 160(17):2633-2638.
66. Factor SH, Whitney CG, Zywicki SS, Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstetrics & Gynecology 2000; 95(3):377-382.
    Posted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 176 KB]
67. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health 2000; 90(2):223-229.
    Copyright held by APHA, posted with permission Download PDF [7 pages, 168 KB]
68. Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A . Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clinical Infectious Diseases 2000; 30(1):71-77.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n1/990542/990542.html
69. Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, Farley MM, Tenover F, Stephens DS . The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. Journal of Infectious Diseases 2000; 182(5):1417-1424.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v182n5/000066/000066.html
70. Gherardi G, Whitney CG, Facklam RR, Beall B. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. Journal of Infectious Diseases 2000; 181(1):216-229.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v181n1/990625/990625.html
71. Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: current controversies. [see comments.]. Obstetrics & Gynecology 2000; 96(1):141-145.
    Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 193 KB]
72. Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Archives of Internal Medicine 2000; 160(1):89-94.
73. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. [see comments.]. Archives of Internal Medicine 2000; 160(10):1399-1408.
74. Jorgensen JH, Weigel LM, Swenson JM, Whitney CG, Ferraro MJ, Tenover FC. Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrobial Agents & Chemotherapy 2000; 44(11):2962-2968.
    Open Access:http://aac.asm.org/cgi/content/full/44/11/2962?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=jorgensen,+jh&searchid=1062612215209_2025&stored_search=&FIRSTINDEX=0&
    search_url=http://aac.asm.org/cgi/search&journalcode=aac
75. McEllistrem MC, Stout JE, Harrison LH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. Journal of Clinical Microbiology 2000; 38(1):351-353.
    Open access: http://jcm.asm.org/cgi/content/full/38/1/351?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=mcellistrem,+mc&searchid=1062614326762_3914&stored_search=&FIRSTINDEX=0&
    search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
76. McEllistrem MC, Pass M, Elliott JA, Whitney CG, Harrison LH. Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. Journal of Clinical Microbiology 2000; 38(12):4367-4372.
    Open Access:http://jcm.asm.org/cgi/content/full/38/12/4367?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=mcellistrem,+mc&searchid=1062614326762_3914&stored_search=&FIRSTINDEX=0&
    search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
77. Metlay JP, Hofmann J, Cetron MS, Fine MJ, Farley MM, Whitney C et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clinical Infectious Diseases 2000; 30(3):520-528.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n3/990974/990974.html
78. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. [see comments.]. New England Journal of Medicine 2000; 342(10):681-689.
79. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. [see comments.]. Annals of Internal Medicine 2000; 132(3):182-190.
    Open Access: http://www.annals.org/cgi/content/full/132/3/182
80. Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Clinical Infectious Diseases 2000; 30(1):212-213.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n1/990425/990425.html
81. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. [see comments.]. New England Journal of Medicine 2000; 342(1):15-20.
82. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. [Review] [57 refs]. Infection Control & Hospital Epidemiology 2000; 21(7):473-483.
83. Schuchat A. Neonatal group B streptococcal disease--screening and prevention. [letter; comment.]. New England Journal of Medicine 2000; 343(3):209-210.
84. Tondella ML, Popovic T, Rosenstein NE, Lake DB, Carlone GM, Mayer LW et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. Journal of Clinical Microbiology 2000; 38(9):3323-3328.
    Open Access:http://jcm.asm.org/cgi/content/full/38/9/3323?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=tondella,+ml&searchid=1062614442508_3929&stored_search=&FIRSTINDEX=0&
    search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
85. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. [see comments.]. New England Journal of Medicine 2000; 343(26):1917-1924.
86. Sacchi CT, Whitney AM, Popovic T, Beall DS, Reeves MW, Plikaytis BD, Rosenstein NE, Perkins BA,Tondella ML, Mayer LW .. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000; 182(4):1169-1176.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v182n4/000497/000497.html
87. Centers for Disease Control and Prevention. Adoption of perinatal group B streptococcal disease
    prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998. MMWR Morb Mortal Wkly Rep 2000; 49(11):228-232.
88. Harrison LH. Preventing meningococcal infection in college students. Clin Infect Dis 2000; 30(4):648-651.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n4/000029/000029.html
89. Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE et al. Genetic locus for streptolysin S production by group A streptococcus. Infection & Immunity 68(7):4245-54, 2000.
    Open Access: http://iai.asm.org/cgi/content/full/68/7/4245
90. Centers for Disease Control and Prevention. Resistance of Streptococcus pneumoniae to
    fluoroquinolones--United States, 1995-1999. MMWR - Morbidity & Mortality Weekly Report 2001; 50(37):800-804.
91. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group
    B streptococcal prevention. Pediatrics 2001; 108(5):1094-1098.
92. Brandt ME, Pfaller MA, Hajjeh RA, Hamill RJ, Pappas PG, Reingold AL et al. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrobial Agents & Chemotherapy 2001; 45(11):3065-3069.
    Open Access:http://aac.asm.org/cgi/content/full/45/11/3065?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=brandt,+me&searchid=1062612331051_2042&stored_search=&FIRSTINDEX=0&search
    _url=http://aac.asm.org/cgi/search&journalcode=aac
93. Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Preventive Medicine 2001; 32(5):409-415.
    Reprinted from Preventative Medicine, Vol. 32, Ehresmann et al., 409-415, ©2001, with permission from Elsevier. Download PDF [7 pages, 62 KB]
94. Finn R, Groves C, Coe M, Pass M, Harrison LH. Cluster of serogroup C meningococcal disease associated with attendance at a party. Southern Medical Journal 2001; 94(12):1192-1194.
    Posted with permission of Lippincott, Williams & Wilkins. Download PDF [3 pages, 480 KB]
95. Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, Bustamante A et al. Invasive meningococcal disease in adolescents and young adults. [see comments.]. JAMA 2001; 286(6):694-699.
96. Henning KJ, Hall EL, Dwyer DM, Billmann L, Schuchat A, Johnson JA, Harrison LH, and the Maryland Emerging Infections Program. Invasive group B streptococcal disease in Maryland nursing home residents. Journal of Infectious Diseases 2001; 183(7):1138-1142.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v183n7/001100/001100.html
97. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001; 286(15):1857-1862.
98. Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA et al. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine 2001; 19(31):4566-4575.
    Reprinted from Vaccine, Vol 19, Lingappa et al., “Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States”, ©2001, p. 4566-4575, with permission from Elsevier. http://www.sciencedirect.com/science/journal/0264410X Download PDF [10 pages, 128 KB]
99. Morin CA , Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. Journal of Infectious Diseases 2001; 184(8):1029-1034.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v184n8/010295/010295.html
100. Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH et al. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clinical Infectious Diseases 2001; 33(6):797-805. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n6/001419/001419.html
101. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clinical Infectious Diseases 2001; 33(7):990-996.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n7/010122/010122.html
102. Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. Journal of Clinical Microbiology 2001; 39(1):75-85. Open Access:http://jcm.asm.org/cgi/content/full/39/1/75?maxtoshow=&HITS=10&
     hits=10&RESULTFORMAT=&author1=popovic,+t&author2=rosenstein+na&searchid=1062614588818_
     3954&stored_search=&FIRSTINDEX=0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
103. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285(13):1729-1735.
104. Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L et al.Active bacterial core surveillance of
     the emerging infections program network. Emerg Infect Dis 2001; 7(1):92-99.
105. Schuchat A, Hillier S, Edwards K, Schrag S, Labbok M. Early opportunities for prevention: infections of
     pregnant women and young infants. Emerging Infectious Diseases 2001; 7(3:Suppl):532.
106. Schuchat A. Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clinical Infectious Diseases 2001; 33(6):751-756. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n6/010158/010158.html
107. Stefonek KR, Maerz LL, Nielsen MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. [see comments.]. Obstetrics & Gynecology 2001; 98(5:Pt 1):846-848.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [3 pages, 82KB]
108. Whitney CG, Schaffner W, Butler JC. Rethinking recommendations for use of pneumococcal vaccines in adults. [Review] [123 refs]. Clinical Infectious Diseases 2001; 33(5):662-675.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n5/001755/001755.html
109. Naimi TS, Smith KE, Besser J, Lynfield R. Antimicrobial resistance and judicious antimicrobial use in Minnesota and the United States. Minn Med 2001; 84(4):27-31.
     Open Access: http://www.mnmed.org/publications/MnMed2001/April/Naimi.html
110. Farley MM. Group B streptococcal disease in nonpregnant adults. Clinical Infectious Diseases 33(4):556-61, 2001.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n4/010139/010139.html
111. Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286(10):1201-5, 2001.
112. Mukamel DB, Gold HT, Bennett NM. Cost utility of public clinics to increase pneumococcal vaccines in the elderly. American Journal of Preventive Medicine 21(1):29-34, 2001.
     Reprinted from American Journal of Preventive Medicine, Vol 21, Mukamel, et al., “Cost utility of public clinics to increase pneumococcal vaccines in the elderly” p. 39-34, ©2001, with permission from the American Journal of Preventive Medicine. Download PDF [6 pages, 176KB]
113. Albanese BA, Roche JC, Pass M, Whitney CG, McEllistrem MC, Harrison LH, for the Marylyand Emerging Infections Program. Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clinical Infectious Diseases 2002; 34(1):15-21. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v34n1/010172/010172.
     html
114. Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA et al. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrobial Agents & Chemotherapy 46(8):2477-81, 2002.
     Open Access:http://aac.asm.org/cgi/content/full/46/8/2477?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=skaggs,+ba&searchid=1062612471707_2049&stored_search=&FIRSTINDEX=0&search_
     url=http://aac.asm.org/cgi/search&journalcode=aac
115. Beall B, McEllistrem MC, Gertz RE, Jr., Boxrud DJ, Besser JM, Harrison LH, Jorgensen JH, Whitney CG, for the Active Bacterial Core Surveillance/ Emerging Infections Program Network. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. Journal of Infectious Diseases 2002; 186(1):118-122.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v186n1/011524/011524.html
116. Chuang I, Van Beneden C, Beall B, Schuchat A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis 2002; 35(6):665-670.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n6/020203/020203.html
117. Farley MM, Baughman W, Arnold KE. The Georgia Emerging Infections Program: monitoring trends in invasive pneumococcal disease. Journal of the Medical Association of Georgia 91(2):20-3, 2002.
     Open Access: http://www.journals.uchicago.edu/JID/journal/issues/v186n1/011437/011437.html
118. Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T et al. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. Journal of Infectious Diseases 2002; 186(1):40-48.
     Open Access: http://www.journals.uchicago.edu/JID/journal/issues/v186n1/011437/011437.html
119. McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, Kolano JA, Harrison LH. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. Journal of Infectious Diseases 2002; 185(9):1364-1368.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v185n9/011115/011115.html
120. McEllistrem MC, Mendelsohn AB, Pass M, Elliott JA, Whitney CG, Albanese BA, Harrison LH. Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance. Clinical Infectious Diseases 2002; 34(5):704-707.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v34n5/010830/010830.html
121. Morita JY, Zell ER, Danila R, Farley MM, Hadler J, Harrison LH, Lefkowitz L, Reingold A, Kupronis BA, Schuchat A, and Whitney CG .. Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clinical Infectious Diseases 2002; 35(4):420-427.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n4/010951/010951.html
122. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A, for the Active Bacterial Core Surveillance/Emerging Infections Program Network . Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clinical Infectious Diseases 2002; 35(3):268-276.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n3/020056/020056.html
123. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease.
     Revised guidelines from CDC. Morbidity & Mortality Weekly Report Recommendations & Reports 51(RR-11):1-22, 2002.
124. Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: are reliable way to track antibiotic
     resistance in communities? Emerging Infectious Diseases 2002; 8(5):496-502.
125. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. [see comments.]. New England Journal of Medicine 2002; 347(4):233-239.
126. Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O'Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Maternal & Child Health Journal 6(2):107-14, 2002.
     Reprinted with permission from the Maternal & Child Health Journal. For more information, visit www.wkap.nl/journalhome.htm/1092-7875 Download PDF [8 pages, 61KB]
127. Shevlin JD, Summers-Bean C, Thomas D, Whitney CG, Todd D, Ray SM. A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospital. American Journal of Preventive Medicine 2002; 22(2):92-97.
     Reprinted from the American Journal of Preventative Medicine, vol. 22, Shevlin et al., A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospital, pgs. 92-97, ©2002, with permission from the American Journal of Preventative Medicine. Download PDF [6 pages, 73KB]
128. The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002; 35(8):950-959.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v35n8/020374/020374.html
129. Thomas AR, Cieslak PR, Strausbaugh LJ, Fleming DW. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment. Infect Control Hosp Epidemiol 2002; 23(11):683-688.
130. Centers for Disease Control and Prevention. Assessment of susceptibility testing practices for
     Streptococcus pneumoniae--United States, February 2000. MMWR Morb Mortal Wkly Rep 2002; 51(18):392-394.
131. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae
     type b invasive disease among infants and children--United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002; 51(11):234-237.
132. Passaro DJ, Smitht DS, Hett EC, Reingold AL, Daily P, Van Beneden CA et al. Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99. Epidemiology & Infection 2002; 129(3):471-478. Reprinted with the permission of Cambridge University Press. Download PDF [8 pages, 159KB]
133. Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and
     antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and
     Atlanta. Pediatrics 2002; 110(4):690-695.
134. Centers for Disease Control and Prevention. Serotyping discrepancies in Haemophilus influenzae
     type b disease--United States, 1998-1999. MMWR - Morbidity & Mortality Weekly Report 51(32):706-7, 2002.
135. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infection & Immunity 70(4):2171-7, 2002.
     Open Access: http://iai.asm.org/cgi/content/full/70/4/2171
136. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A et al. Genome and virulence determinants of high virulence community-acquired MRSA.[see comment]. Lancet 359(9320):1819-27, 2002.
     Reprinted from THE LANCET, Vol.359, Baba T et al., “Genome and virulence determinants of high virulence community-acquired MRSA”, ©2002, with permission from Elsevier. http://www.thelancet.com [baba-2002-genome and virulence dets of CA-MRSA.pdf]
137. Fry AM, Zell ER, Schuchat A, Butler JC, Whitney CG. Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine 21(3-4):303-11, 2002. Reprinted from Vaccine, Vol. 21, Fry et al., “Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly”, p. 303-11, ©2002, with permission from Elsevier. http://www.sciencedirect.com/science/journal/0264410X [fry-2002-comparing pneumococcal vaccines in elderly.pdf]
138. Robinson KA, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C, et al.Risk for severe group A
     streptococcal disease among patients' household contacts. Emerg Infect Dis 2003; 9(4):443-447.
139. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.[comment]. New England Journal of Medicine 2003; 348(18):1737-1746.
140. Shepard CW, Rosenstein NE, Fischer M, Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990 to 1999. Pediatric Infectious Disease Journal 2003; 22(5):418-422. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 109KB]
141. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.[comment]. Nature Medicine 2003; 9(4):424-430.
142. Lott TJ, Fundyga RE, Brandt ME, Harrison LH, Sofair AN, Hajjeh RA, Warnock DW. Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. Journal of Clinical Microbiology 2003; 41:1316-1321.
     Open Access:http://jcm.asm.org/cgi/content/full/41/3/1316?maxtoshow=&HITS=10&hits=10&RESULT
     FORMAT=&author1=brandt,+me&searchid=1062612714885_3819&stored_search=&FIRSTINDEX=0&
     search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
143. Fry AM, Facklam RR, Whitney CG, Plikaytis BD, Schuchat A. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States. Journal of Infectious Diseases 188(5):643-52, 2003.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v188n5/30619/30619.html
144. Gertz RE, Jr., McEllistrem MC, Boxrud DJ, Li Z, Sakota V, Thompson TA et al. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. Journal of Clinical Microbiology 2003; 41(9):4194-4216.
     Open Access: http://jcm.asm.org/cgi/content/full/41/9/4194
145. King MD, Whitney CG, Parekh F, Farley MM, Active Bacterial Core Surveillance Team/Emerging Infections Program. Recurrent invasive pneumococcal disease: a population-based assessment. Clinical Infectious Diseases 2003; 37(8):1029-1036.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v37n8/31012/31012.html
146. Kupronis BA, Richards CL, Whitney CG, Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community.[see comment]. Journal of the American Geriatrics Society 2003; 51(11):1520-1525.
147. Igwe EI, Shewmaker PL, Facklam RR, Farley MM, Van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiology Letters 2003; 229(2):259-264.
     Reprinted from FEMS Microbiology Letters, Vol. 229, Igwe et al., Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans., pgs 259-264, ©2003, with permission from Elsevier. For more information, visit Http://www.sciencedirect.com/science/journal/03781097 Download PDF [6 pages, 294 KB]
148. Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, et al.Aggregated
     antibiograms and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 2003; 9(9): 1089-1095.
149. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination.[see comment][erratum appears in J Pediatr. 2004 Mar;144(3):412]. Journal of Pediatrics 143(4):438-44, 2003. Open Access: http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=full&id=as0022347603003317For more information visit The Journal of Pediatrics
150. Li Z, Sakota V, Jackson D, Franklin AR, Beall B, Active Bacterial Core Surveillance/Emerging Infections Program. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. Journal of Infectious Diseases 188(10):1587-92, 2003.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v188n10/30894/30894.html
151. McEllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. Journal of Infectious Diseases 188(11):1679-84, 2003.
     Open Access: http://www.journals.uchicago.edu/JID/journal/issues/v188n11/30794/30794.html
152. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. [Review] [72 refs]. The Lancet Infectious Diseases 3(4):201-13, 2003.
153. Naimi TS, Anderson D, O'Boyle C, Boxrud DJ, Johnson SK, Tenover FC, Lynfield R. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia. Clinical Infectious Diseases 36(12):1609-12, 2003.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v36n12/30400/30400.html
154. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.[see comment]. JAMA 290(22):2976-84, 2003.
155. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al. Community-acquired
     methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide
     emergence. Emerging Infectious Diseases 9(8):978-84, 2003.
156. Butler JC, Bosshardt SC, Phelan M, Moroney SM, Tondella ML, Farley MM, Schuchat A, Fields BS. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. Journal of Infectious Diseases 187(9):1416-23, 2003.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v187n9/30218/30218.html
157. Ogunmodede F, Virnig BA, Danila R, Lynfield R. Prevention of perinatal group B streptococcal disease in Minnesota: results from a retrospective cohort study and new prevention guidelines. Minnesota Medicine 86(8):40-5, 2003.
     Open Access: http://www.mmaonline.net/publications/MNMed2003/August/Lynfield.html
158. Balter S, Zell ER, O'Brien KL, Roome A, Noga H, Thayu M et al. Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatric Infectious Disease Journal 22(10):853-7, 2003. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 208 KB]
159. LaClaire LL, Tondella ML, Beall DS, Noble CA, Raghunathan PL, Rosenstein NE et al. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. Journal of Clinical Microbiology 41(1):393-6, 2003.
     Open Access: http://jcm.asm.org/cgi/content/full/41/1/393
160. Satola SW, Schirmer PL, Farley MM. Genetic analysis of the capsule locus of Haemophilus influenzae serotype f. Infection & Immunity 71(12):7202-7, 2003.
     Open Access: http://iai.asm.org/cgi/content/full/71/12/7202
161. Satola SW, Schirmer PL, Farley MM. Complete sequence of the cap locus of Haemophilus influenzae serotype b and nonencapsulated b capsule-negative variants. Infection & Immunity 71(6):3639-44, 2003.
     Open Access: http://iai.asm.org/cgi/content/full/71/6/3639
162. Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstetrics & Gynecology 102(4):753-60, 2003.
     Posted with permission from Lippincott, Williams & Wilkins. Download PDF [8 pages, 102KB]
163. Centers for Disease Control and Prevention (CDC). Effect of new susceptibility breakpoints on reporting
     of resistance in Streptococcus pneumoniae--United States, 2003. MMWR Morbidity & Mortality Weekly Report 2004; 53(7):152-154.
164. Flannery B, Stephanie Schrag, Nancy M.Bennett, Ruth Lynfield, Lee H.Harrison, Arthur Reingold et al. Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus pneumoniae Infections. JAMA 291, 2197-2203. 2004.
165. McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn AB, Fonseca Pacheco AG et al.
     Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerging Infectious Diseases 10(3):451-6, 2004.
166. McEllistrem MC, Noller AC, Visweswaran S, Adams JM, Harrison LH. Serotype 14 variants of the France 9V(-3) clone from Baltimore, Maryland, can be differentiated by the cpsB gene. Journal of Clinical Microbiology 42(1):250-6, 2004.
     Open Access: http://jcm.asm.org/cgi/content/full/42/1/250
167. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. Journal of Clinical Microbiology 42(4):1519-27, 2004.
     Open Access: http://jcm.asm.org/cgi/content/full/42/4/1519
168. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother 2004; 48(9):3491-3497.
     Open Access: http://aac.asm.org/cgi/content/full/48/9/3491
169. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J 2004; 23(8):726-731.
     Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 590KB]
170. Schrag SJ, McGee L, Whitney CG, Beall B, Craig AS, Choate ME et al. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother 2004; 48(8):3016-3023.
     Open Access: http://aac.asm.org/cgi/content/full/48/8/3016
171. Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention (CDC).
     Laboratory practices for prenatal group B streptococcal screening--seven states, 2003. MMWR 2004; Morbidity & Mortality Weekly Report. 53(23):506-509.
172. Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention (CDC).
     Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States,
     2000-2003. MMWR 2004; Morbidity & Mortality Weekly Report. 53(23):502-505.
173. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, Ng VL, Chansky K, Edlin B, Chambers HF . Origins of community strains of methicillin-resistant Staphylococcus aureus.[erratum appears in Clin Infect Dis. 2004 Jul 15;39(2):291 Note: Edlin, B [corrected to Edlin, BR]]. Clinical Infectious Diseases 39(1):47-54, 2004.
     Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v39n1/32585/32585.html
     Open access link for erratum: http://www.journals.uchicago.edu/CID/journal/issues/v39n2/34274/
     34274.html
174. Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. Journal of Clinical Microbiology 42(1):320-8, 2004.
     Open Access: http://jcm.asm.org/cgi/content/full/42/1/320
175. Raghunathan PL, Bernhardt SA, Rosenstein NE. Opportunities for control of meningococcal disease in the United States. [Review] [138 refs]. Annual Review of Medicine 55:333-53, 2004.
     Reprinted, with permission, from the Annual Review of Medicine, Volume 55, ©2004 by Annual Reviews
     www.annualreviews.org Download PDF [23 pages, 245KB]
176. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA et al. Methicillin-resistant Staphylococcus aureus disease in three communities.[see comment]. New England Journal of Medicine 352(14):1436-44, 2005.
177. Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, Gay K et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365(9462):855-63, 2005.
178. Greene CM, Van Beneden CA, Javadi M, Skoff TH, Beall B, Facklam R et al. Cluster of deaths from group A streptococcus in a long-term care facility-- Georgia, 2001. American Journal of Infection Control 33(2):108-13, 2005.
179. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. American Journal of Medicine 118(3):285-91, 2005.

To Top

Bibliography by Activity: Foodborne Diseases Active Surveillance Network (FoodNet)

1. Hedberg CW, MacDonald KL, Osterholm MT. Changing epidemiology of food-borne disease: a Minnesota perspective. [Review] [18 refs]. Clinical Infectious Diseases 18(5):671-80; quiz 681-2, 1994.
2. Roberts CL, Morin C, Addiss DG, Wahlquist SP, Mshar PA, Hadler JL. Factors influencing Cryptosporidium testing in Connecticut. Journal of Clinical Microbiology 1996; 34(9):2292-2293.
   Open Access:http://jcm.asm.org/cgi/content/abstract/34/9/2292?maxtoshow=&HITS=10&hits=
   10&RESULTFORMAT=&author1=roberts,+c&searchid=1062614061589_3889&stored_search=&FIRST
   INDEX=0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
3. Hedberg CW, Hirschhorn N. Why foodborne disease surveillance is critical to the safety of our food supply. Am J Public Health 1996; 86(8 Pt 1):1076-1077.
   Copyright held by APHA, posted with permission Download PDF [3 pages, 188 KB]
4. Hedberg CW. Foodborne disease: how to respond? Med J Aust 1996; 165(11-12):667.
   Reproduced with permission, ©1996. The Medical Journal of Australia Download PDF [1 page, 225 KB]
5. Hennessy TW, Hedberg CW, Slutsker L, White KE, Besser-Wiek JM, Moen ME et al. A national outbreak of Salmonella enteritidis infections from ice cream. The Investigation Team.[see comment]. New England Journal of Medicine 334(20):1281-6, 1996.
6. Centers for Disease Control and Prevention. Foodborne Diseases Active Surveillance Network, 1996. MMWR - Morbidity & Mortality Weekly Report 1997; 46(12):258-261.
7. Bender JB, Hedberg CW, Besser JM, Boxrud DJ, MacDonald KL, Osterholm MT. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. New England Journal of Medicine 1997; 337(6):388-394.
8. Morin CA , Roberts CL, Mshar PA, Addiss DG, Hadler JL. What do physicians know about cryptosporidiosis? A survey of Connecticut physicians. Archives of Internal Medicine 1997; 157(9):1017-1022.
9. Keene WE, Sazie E, Kok J, Rice DH, Hancock DD, Balan VK et al. An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 1997; 277(15):1229-1231.
10. Lynfield R, Guerina NG. Toxoplasmosis. Pediatr Rev 1997; 18(3):75-83.
11. Centers for Disease Control and Prevention. Foodborne Diseases Active Surveillance Network (FoodNet). Emerging Infectious Diseases 1997; 3(4):581-583.
12. Keene WE, Hedberg K, Herriott DE, Hancock DD, McKay RW, Barrett TJ, Fleming DW. A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk. Journal of Infectious Diseases 1997; 176(3):815-818.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n3/se29_755/se29_755.web.pdf
13. Hedberg CW, Savarino SJ, Besser JM, Paulus CJ, Thelen VM, Myers LJ, Cameron DN, Barrett TJ, Kaper JB, Osterholm MT, and the Investigation Team. An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. Journal of Infectious Diseases 176(6):1625-8, 1997.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n6/de26_1610/de26_1610.
    web.pdf
14. Centers for Disease Control and Prevention. From the Centers for Disease Control and Prevention. Incidence of foodborne illnesses--FoodNet, 1997. JAMA 1998; 280(19):1651-1652.
15. Centers for Disease Control and Prevention. Incidence of foodborne illnesses--FoodNet, 1997. MMWR - Morbidity & Mortality Weekly Report 1998; 47(37):782-786.
16. Angulo FJ, Voetsch AC, Vugia D, Hadler JL, Farley M, Hedberg C et al. Determining the burden of human illness from food borne diseases. CDC's emerging infectious disease program Food Borne Diseases Active Surveillance Network (FoodNet). Veterinary Clinics of North America - Food Animal Practice 1998; 14(1):165-172.
17. Binder S, Khabbaz R, Swaminathan B, Tauxe R, Potter M. The national food safety initiative. Emerging Infectious Diseases 1998; 4(2):347-351.
18. Centers for Disease Control and Prevention. Outbreak of cryptosporidiosis associated with a water
    sprinkler fountain--Minnesota, 1997. MMWR Morb Mortal Wkly Rep 1998; 47(40):856-860.
19. Centers for Disease Control and Prevention. Incidence of foodborne illnesses: preliminary data from
    the Foodborne Diseases Active Surveillance Network (FoodNet)--United States, 1998. MMWR - Morbidity & Mortality Weekly Report 1999; 48(9):189-194.
20. Yang S. FoodNet and Enter-net: emerging surveillance programs for foodborne diseases. Emerging Infectious Diseases 1998; 4(3):457-458.
21. Baer JT, Vugia DJ, Reingold AL, Aragon T, Angulo FJ, Bradford WZ. HIV infection as a risk factor for
    shigellosis. Emerging Infectious Diseases 1999; 5(6):820-823.
22. Bender JB, Smith KE, Hedberg C, Osterholm MT. Food-borne disease in the 21st century. What challenges await us?. [Review] [15 refs]. Postgraduate Medicine 1999; 106(2):109-112.
    Open access: http://www.postgradmed.com/issues/1999/08_99/bender.htm
23. Keene WE. Lessons from investigations of foodborne disease outbreaks. JAMA 1999; 281(19):1845-1847.
24. Lynfield R, Hsu HW, Guerina NG. Screening methods for congenital toxoplasma and risk of disease. [letter; comment.]. Lancet 1999; 353(9168):1899-1900.
    Reprinted with permission from Elsevier (The Lancet, 1999; 383(9168):1899-1900) For more information, visit
    http://www.sciencedirect.com/science/journal/01406736 Download PDF [2 pages, 62 KB]
25. Mead PS, Slutsker L, Griffin PM, Tauxe RV. Food-related illness and death in the united states reply to
    Dr. Hedberg. Emerging Infectious Diseases 1999; 5(6):841-842.
26. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C et al.Food-related illness and death in
    the United States. [see comments.]. [Review] [107 refs]. Emerging Infectious Diseases 1999; 5(5):607-625.
27. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. [see comments.]. New England Journal of Medicine 1999; 340(20):1525-1532.
28. Hedberg CW, Angulo FJ, White KE, Langkop CW, Schell WL, Stobierski MG et al. Outbreaks of salmonellosis associated with eating uncooked tomatoes: implications for public health. The Investigation Team. Epidemiol Infect 1999; 122(3):385-393.
    Reprinted with the permission of Cambridge University Press Download PDF [9 pages, 238 KB]
29. Centers for Disease Control and Prevention. Outbreaks of Shigella sonnei infection associated with
    eating fresh parsley--United States and Canada, July-August 1998. MMWR - Morbidity & Mortality Weekly Report 1999; 48(14):285-289.
30. Van Beneden CA, Keene WE, Strang RA, Werker DH, King AS, Mahon B et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999; 281(2):158-162.
31. Hilborn ED, Mermin JH, Mshar PA, Hadler JL, Voetsch A, Wojtkunski C et al. A multistate outbreak of Escherichia coli O157:H7 infections associated with consumption of mesclun lettuce. Arch Intern Med 1999; 159(15):1758-1764.
32. McNeil MM, Sweat LB, Carter SL, Jr., Watson CB, Holloway JT, Manning R et al. A Mexican restaurant-associated outbreak of Salmonella Enteritidis type 34 infections traced to a contaminated egg farm. Epidemiology & Infection 122(2):209-15, 1999.
    Reprinted with permission from Cambridge University Press. Download PDF [7 pages, 220 KB]
33. Parashar UD, Chung MA, Holman RC, Ryder RW, Hadler JL, Glass RI. Use of state hospital discharge data
    to assess the morbidity from rotavirus diarrhea and to monitor the impact of a rotavirus immunization
    program: A pilot study in Connecticut. Pediatrics 104(3 Pt 1):489-94, 1999.
34. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne
    illnesses--selected sites, United States, 1999. [erratum appears in MMWR Morb Mortal Wkly Rep 2000 Apr 7;49(13):286.]. MMWR Morb Mortal Wkly Rep 2000; 49(10):201-205.
35. Centers for Disease Control and Prevention. FoodNet reports decline in some foodborne disease. Journal of the American Veterinary Medical Association 2000; 216(12):1892.
36. Centers for Disease Control and Prevention. From the Centers for Disease Control and Prevention. Preliminary Foodnet data on the incidence of foodborne illnesses--selected sites, United States, 1999. JAMA 2000; 283(14):1818-1819.
37. Dietz V, Vugia D, Nelson R, Wicklund J, Nadle J, McCombs KG et al. Active, multisite, laboratory-based surveillance for Cryptosporidium parvum. American Journal of Tropical Medicine & Hygiene 2000; 62(3):368-372.
    Posted with permission from The American Society of Tropical Medicine and Hygiene. Download PDF [5 pages, 343 KB]
38. Hilborn ED, Mshar PA, Fiorentino TR, Dembek ZF, Barrett TJ, Howard RT et al. An outbreak of Escherichia coli O157:H7 infections and haemolytic uraemic syndrome associated with consumption of unpasteurized apple cider. Epidemiology & Infection 2000; 124(1):31-36.
    Reprinted with the permission of Cambridge University Press Download PDF [6 pages, 153 KB]
39. Jones TF. The Tennessee Foodborne Illness Surveillance Network (FoodNet). Tennessee Medicine 2000; 93(9):334-335.
    Republished with the permission of Tennessee Medical Association and Tennessee Medicine, ©2000
    Download PDF [2 pages, 333 KB]
40. Karras DJ. Incidence of foodborne illnesses: preliminary data from the foodborne diseases active surveillance network (FoodNet). [Review] [26 refs]. Annals of Emergency Medicine 2000; 35(1):92-93.
    Reprinted from Annals Of Emergency Medicine, vol 35, Karras DJ, “Incidence of foodborne illnesses: preliminary data from the foodborne diseases active surveillance network (FoodNet)” p. 92-93, ©2000, with permission from the American College of Emergency Physicians.
    [karras-2000-incidince of foodborne illness.htm]
41. Replogle ML, Fleming DW, Cieslak PR. Emergence of antimicrobial-resistant shigellosis in Oregon. Clinical Infectious Diseases 2000; 30(3):515-519.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v30n3/990964/990964.html
42. Shiferaw B, Yang S, Cieslak P, Vugia D, Marcus R, Koehler J et al. Prevalence of high-risk food consumption and food-handling practices among adults: a multistate survey, 1996 to 1997. The Foodnet Working Group. Journal of Food Protection 2000; 63(11):1538-1543.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: CA State Health Division, OR Health Division, Yale University, GA Div. of Public Health, MN Dept. of Public Health, CDC. Download PDF [6 pages, 461KB]
43. Wallace DJ, Van Gilder T, Shallow S, Fiorentino T, Segler SD, Smith KE et al. Incidence of foodborne illnesses reported by the foodborne diseases active surveillance network (FoodNet)-1997. FoodNet Working Group. J Food Prot 2000; 63(6):807-809.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: Emerging Infections Programs in CA, CT, GA; OR Health Division; MN Dept. of Health; US Dept. of Agriculture; Food and Drug Administration; CDC. Download PDF [3 pages, 277KB]
44. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne
    illnesses--selected sites, United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50(13):241-246.
45. Centers for Disease Control and Prevention. From the Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne illnesses--selected sites, United States, 2000. JAMA 2001; 285(16):2071-2073.
46. Bender JB, Hedberg CW, Boxrud DJ, Besser JM, Wicklund JH, Smith KE et al. Use of molecular subtyping in surveillance for Salmonella enterica serotype typhimurium. New England Journal of Medicine 2001; 344(3):189-195.
47. Frenzen PD, DeBess EE, Hechemy KE, Kassenborg H, Kennedy M, McCombs K et al. Consumer acceptance of irradiated meat and poultry in the United States. Journal of Food Protection 2001; 64(12):2020-2026.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: US Department of Agriculture, Oregon Health Div., NY State Dept. of Health, MN Dept. of Health, GA Div. of Public Health, CA Emerging Infections Program, CDC. Download PDF [7 pages, 130 KB]
48. Hedberg CW, Smith KE, Besser JM, Boxrud DJ, Hennessy TW, Bender JB, Henderson FA, Osterholm, MT. Limitations of pulsed-field gel electrophoresis for the routine surveillance of Campylobacter infections. [letter; comment.]. Journal of Infectious Diseases 2001; 184(2):242-244.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v184n2/010160/010160.html
49. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. [see comments.]. New England Journal of Medicine 2001; 345(16):1155-1160.
50. Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S et al. A nosocomial outbreak of fluoroquinolone-resistant salmonella infection. New England Journal of Medicine 2001; 344(21):1572-1579.
51. Samuel MC, Portnoy D, Tauxe RV, Angulo FJ, Vugia DJ. Complaints of foodborne illness in San Francisco, California, 1998. Journal of Food Protection 2001; 64(8):1261-1264.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: California Emerging Infections Program and Dept. of Health Services, San Francisco Dept. of Public Health, CDC. Download PDF [4 pages, 941KB]
52. Winquist AG, Roome A, Mshar R, Fiorentino T, Mshar P, Hadler J. Outbreak of campylobacteriosis at a senior center. Journal of the American Geriatrics Society 2001; 49(3):304-307.
53. McCarthy TA, Barrett NL, Hadler JL, Salsbury B, Howard RT, Dingman DW et al.Hemolytic-Uremic
    Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999. Pediatrics 2001; 108(4):E59.
54. Jones TF, Gerber DE. Perceived etiology of foodborne illness among public health personnel. Emerg Infect Dis 2001; 7(5):904-905.
55. Hall JA, Goulding JS, Bean NH, Tauxe RV, Hedberg CW. Epidemiologic profiling: evaluating foodborne outbreaks for which no pathogen was isolated by routine laboratory testing: United States, 1982-9. Epidemiology & Infection 127(3):381-7, 2001.
    Reprinted with permission from Cambridge University Press. Download PDF [7 pages, 142 KB]
56. Zhao T, Doyle MP, Zhao P, Blake P, Wu FM. Chlorine inactivation of Escherichia coli O157:H7 in water. Journal of Food Protection 64(10):1607-9, 2001.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: University of Georgia, GA State Public Health Dept.
    Download PDF [3 pages, 95KB]
57. Centers for Disease Control and Prevention. Preliminary FoodNet data on the incidence of foodborne
    illnesses--selected sites, United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51(15):325-329.
58. Herikstad H, Yang S, Van Gilder TJ, Vugia D, Hadler J, Blake P et al. A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996-7. Epidemiology & Infection 129(1):9-17, 2002.
    Reprinted with the permission of Cambridge University Press Download PDF [9 pages, 139 KB]
59. Rabatsky-Ehr T, Dingman D, Marcus R, Howard R, Kinney A, Mshar P. Deer meat as the source for a
    sporadic case of Escherichia coli O157:H7 infection, Connecticut. Emerging Infectious Diseases 2002; 8(5):525-527.
60. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 2002; 155(10):941-948.
61. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An outbreak of community-acquired foodborne
    illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2002; 8(1):82-84.
62. Vanden Eng J, Marcus R, Hadler JL, Imhoff B, Vugia DJ, Cieslak P, et al.Consumer attitudes
    and inappropriate use of antibiotics. Emerg Infect Dis 2003;9(9):1128-1135.
63. Centers for Disease Control and Prevention. Preliminary FoodNet Data on the Incidence
    of Foodborne Illnesses --- Selected Sites, United States, 2002. MMWR 2003;52(15):340-343.
64. Naimi TS, Wicklund JH, Olsen SJ, Krause G, Wells JG, Bartkus JM et al. Concurrent outbreaks of Shigella sonnei and enterotoxigenic Escherichia coli infections associated with parsley: implications for surveillance and control of foodborne illness. Journal of Food Protection 66(4):535-41, 2003.
    Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: MN Dept. of Health, CDC. Download PDF [7 pages, 351KB]
65. Kaufman SS, Chatterjee NK, Fuschino ME, Magid MS, Gordon RE, Morse DL et al. Calicivirus enteritis in an intestinal transplant recipient. American Journal of Transplantation 3(6):764-8, 2003.
66. Allos BM, Moore MR, Griffin PM, Tauxe RV. Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. Clinical Infectious Diseases 2004; 38(Suppl 3):S115-120.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32103/32103.html
67. Bender JB, Smith KE, McNees AA, Rabatsky-Ehr TR, Segler SD, Hawkins MA et al. Factors affecting surveillance data on Escherichia coli O157 infections collected from FoodNet sites, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S157-164.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32109/32109.html
68. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of
    infection with pathogens transmitted commonly through food--selected sites, United States, 2003. MMWR Morbidity & Mortality Weekly Report 2004; 53(16):338-343.
69. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, Reddy S, Ahuja SD, Helfrick DL, Hardnett F, Carter M, Anderson B, Tauxe RV, for the Emerging Infections Program FoodNet Working Group . Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S285-296.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32125/32125.html
70. Glynn MK, Reddy V, Hutwagner L, Rabatsky-Ehr T, Shiferaw B, Vugia DJ, Segler S, Bender J, Barrett TJ, Angulo FJ, and the Emerging Infections Program FoodNet Working Group . Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. Clinical Infectious Diseases 2004; 38(Suppl 3):S227-236.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32118/32118.html
71. Hardnett FP, Hoekstra RM, Kennedy M, Charles L, Angulo FJ, Emerging Infections Program FoodNet Working Group. Epidemiologic issues in study design and data analysis related to FoodNet activities. Clinical Infectious Diseases 2004; 38(Suppl 3):S121-126.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32131/32131.html
72. Hennessy TW, Cheng LH, Kassenborg H, Ahuja SD, Mohle-Boetani J, Marcus R, Shiferaw B, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Egg consumption is the principal risk factor for sporadic Salmonella serotype Heidelberg infections: a case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S237-243.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32119/32119.html
73. Hennessy TW, Marcus R, Deneen V, Reddy S, Vugia D, Townes J, Bardsley M, Swerdlow D, Angulo FJ, and the Emerging Infections Program FoodNet Working Group . Survey of physician diagnostic practices for patients with acute diarrhea: clinical and public health implications. Clinical Infectious Diseases 2004; 38(Suppl 3):S203-211.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32115/32115.html
74. Imhoff B, Morse D, Shiferaw B, Hawkins M, Vugia D, Lance-Parker S, Hadler J, Medus C, Kennedy M, Moore MR, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group . Burden of self-reported acute diarrheal illness in FoodNet surveillance areas, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S219-226.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32117/32117.html
75. Jones TF, Imhoff B, Samuel M, Mshar P, McCombs KG, Hawkins M et al. Limitations to successful investigation and reporting of foodborne outbreaks: an analysis of foodborne disease outbreaks in FoodNet catchment areas, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S297-302.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32114/32114.html
76. Kassenborg HD, Smith KE, Vugia DJ, Rabatsky-Ehr T, Bates MR, Carter MA,  Dumas NB, Cassidy MP, Marano N, Tauxe RV, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clinical Infectious Diseases 2004; 38(Suppl 3):S279-284.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32124/32124.html
77. Kassenborg HD, Hedberg CW, Hoekstra M, Evans MC, Chin AE, Marcus R, Vugia DJ, Smith K, Ahuja SD, Slutsker L, Griffin PM, for the Emerging Infections Program FoodNet Working Group . Farm visits and undercooked hamburgers as major risk factors for sporadic Escherichia coli O157:H7 infection: data from a case-control study in 5 FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S271-278.
    open access: http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32123/32123.html
78. Kennedy M, Villar R, Vugia DJ, Rabatsky-Ehr T, Farley MM, Pass M et al. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S142-148.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32106/32106.html
79. Kimura AC, Reddy V, Marcus R, Cieslak PR, Mohle-Boetani JC, Kassenborg HD,  Segler SD, Hardnett FP, Barrett T, Swerdlow DL, for the Emerging Infections Program FoodNet Working Group . Chicken consumption is a newly identified risk factor for sporadic Salmonella enterica serotype Enteritidis infections in the United States: a case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S244-252.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32120/32120.htm
80. Marcus R, Rabatsky-Ehr T, Mohle-Boetani JC, Farley M, Medus C, Shiferaw B et al. Dramatic decrease in the incidence of Salmonella serotype Enteritidis infections in 5 FoodNet sites: 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S135-141.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32105/32105.html
81. Mermin J, Hutwagner L, Vugia D, Shallow S, Daily P, Bender J, Koehler J, Marcus R, Angulo FJ, for the Emerging Infections Program FoodNet Working Group . Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clinical Infectious Diseases 2004; 38(Suppl 3):S253-261.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32121/32121.html
82. Ray SM, Ahuja SD, Blake PA, Farley MM, Samuel M, Fiorentino T et al. Population-based surveillance for Yersinia enterocolitica infections in FoodNet sites, 1996-1999: higher risk of disease in infants and minority populations. Clinical Infectious Diseases 2004; 38(Suppl 3):S181-189.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32112/32112.html
83. Rees JR, Pannier MA, McNees A, Shallow S, Angulo FJ, Vugia DJ. Persistent diarrhea, arthritis, and other complications of enteric infections: a pilot survey based on California FoodNet surveillance, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S311-317.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32130/32130.html
84. Rowe SY, Rocourt JR, Shiferaw B, Kassenborg HD, Segler SD, Marcus R, Daily PJ, Hardnett FP, Slutsker L, for the Emerging Infections Program FoodNet Working Group . Breast-feeding decreases the risk of sporadic salmonellosis among infants in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl 3):S262-270.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32122/32122.html
85. Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S165-174.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32110/32110.html
86. Shiferaw B, Shallow S, Marcus R, Segler S, Soderlund D, Hardnett FP, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group. Trends in population-based active surveillance for shigellosis and demographic variability in FoodNet sites, 1996-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S175-180.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32111/32111.html
87. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S, Marcus R et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clinical Infectious Diseases 2004; 38: S127-134.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32104/32104.html
88. Voetsch AC, Angulo FJ, Rabatsky-Ehr T, Shallow S, Cassidy M, Thomas SM et al. Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000. Clinical Infectious Diseases 2004; 38: S190-S197 .
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32113/32113.html
89. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S et al. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clinical Infectious Diseases 2004; 38(Suppl 3):S149-156.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32107/32107.html
90. Wong S, Marcus R, Hawkins M, Shallow S, McCombs KG, Swanson E, Anderson B, Shiferaw B, Garman R, Noonan K, and Van Gilder T, for the Emerging Infections Program FoodNet Working Group. Physicians as food-safety educators: a practices and perceptions survey. Clinical Infectious Diseases 2004; 38:S212-18.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32116/32116.html
91. Chatterjee NK, Moore DW, Monroe SS, Glass RI, Cambridge MJ, Kondracki SF, Morse DL . Molecular epidemiology of outbreaks of viral gastroenteritis in New York State, 1998-1999. Clinical Infectious Diseases 2004; 38(Suppl 3):S303-310.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32127/32127.html
92. Rabatsky-Ehr T, Whichard J, Rossiter S, Holland B, Stamey K, Headrick ML et al. Multidrug-resistant
    strains of Salmonella enterica Typhimurium, United States, 1997-1998. Emerging Infectious Diseases 10(5):795-801, 2004.
93. Rosenberg J, Jarvis WR, Abbott SL, Vugia DJ, California Emerging Infections Program. Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. Infection Control & Hospital Epidemiology 25(5):408-12, 2004.
94. Kimura AC, Johnson K, Palumbo MS, Hopkins J, Boase JC, Reporter R et al. Multistate shigellosis
    outbreak and commercially prepared food, United States. Emerging Infectious Diseases 10(6):1147-9, 2004.
95. Roy SL, DeLong SM, Stenzel SA, Shiferaw B, Roberts JM, Khalakdina A et al. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. Journal of Clinical Microbiology 42(7):2944-51, 2004.
    Open Access: http://jcm.asm.org/cgi/content/full/42/7/2944
96. Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR et al. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.[see comment]. Emerging Infectious Diseases 10(6):1102-9, 2004. Open Access: http://www.cdc.gov/ncidod/EID/vol10no6/03-0635.htm
97. Jones JL, Lopez A, Wahlquist SP, Nadle J, Wilson M, Emerging Infections Program FoodNet Working Group. Survey of clinical laboratory practices for parasitic diseases. Clinical Infectious Diseases 2004; 38(Suppl 3):S198-202. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38nS3/32114/32114.html
98. Smith KE, Stenzel SA, Bender JB, Wagstrom E, Soderlund D, Leano FT et al. Outbreaks of enteric infections caused by multiple pathogens associated with calves at a farm day camp. Pediatr Infect Dis J 2004; 23(12):1098-1104. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [7 pages, 382KB]
99. Jones TF, Chaves SS, Barrett TJ, Moore MR. Epidemiology of bacterial enteric infections under active surveillance in Tennessee and Georgia, 2000-2002. Tenn Med 2004; 97(7):319-321.
    Republished with the permission of Tennessee Medical Association and Tennessee Medicine, ©2004
    Download PDF [3 pages, 686 KB]
100. Lee R, Beatty ME, Bogard AK, Esko MP, Angulo FJ, Selman C et al. Prevalence of high-risk egg-preparation practices in restaurants that prepare breakfast egg entrees: an EHS-Net study. J Food Prot 2004; 67(7):1444-1450. Reprinted with permission from the Journal of Food Protection. Copyright held by the International Association for Food Protection, Des Moines, Iowa, USA. Authors’ affiliations: MN Dept. of Health, CA Emerging Infections Program, CDC. Download PDF [7 pages, 69 KB]
101. Chang HG, Tserenpuntsag B, Kacica M, Smith PF, Morse DL, Chang HG et al. Hemolytic uremic
     syndrome incidence in New York. Emerg Infect Dis 2004; 10(5):928-931.
102. Jones TF, Pavlin BI, LaFleur BJ, Ingram LA, Schaffner W. Restaurant inspection scores and
     foodborne disease. Emerg Infect Dis 2004; 10(4):688-692.
103. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. Journal of Infectious Diseases 2004;(6):1150-1157.
104. Morotti RA, Kaufman SS, Fishbein TM, Chatterjee NK, Fuschino ME, Morse DL et al. Calicivirus infection in pediatric small intestine transplant recipients: pathological considerations. Human Pathology 35(10):1236-40, 2004.
105. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005; 191(4):554-561.
106. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of
     infection with pathogens transmitted commonly through food--10 sites, United States, 2004. MMWR Morbidity & Mortality Weekly Report 54(14):352-6, 2005.
107. Deneen VC, Hunt JM, Paule CR, James RI, Johnson RG, Raymond MJ et al. The impact of foodborne calicivirus disease: the Minnesota experience. Journal of Infectious Diseases 2000; 181:(Suppl- 2):281-283.
     Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v181nS2/990757/990757.web.pdf

To Top

Bibliography by Activity: General EIP

1. Bryan RT, Pinner RW, Berkelman RL. Emerging infectious diseases in the United States, Improved surveillance, a requisite for prevention. [Review] [38 refs]. Annals of the New York Academy of Sciences 1994; 740:346-361.
   Posted with permission. For more information, visit www.nyas.org and www.annalsnyas.org Download
   PDF [16 pages, 1.9 MB]
2. Berkelman RL, Pinner RW, Hughes JM. Addressing emerging microbial threats in the United States. JAMA 1996; 275(4):315-317.
3. Pinner RW. Addressing the challenges of emerging infectious disease. [Review] [23 refs]. American Journal of the Medical Sciences 1996; 311(1):3-8.
4. Stephens DS, Moxon ER, Adams J, Altizer S, Antonovics J, Aral S et al. Emerging and reemerging infectious diseases: a multidisciplinary perspective. Am J Med Sci 1998; 315(2):64-75.
   Posted with permission. Copyright held by Lippincott, Williams & Wilkins [stephens-1998-emerging and reemerging ID - a multidisc.html]
5. Danila RN, Lexau C, Lynfield R, Moore KA, Osterholm MT. Addressing emerging infections. The partnership between public health and primary care physicians. [Review] [15 refs]. Postgraduate Medicine 1999; 106(2):90-92. Open Access:http://www.postgradmed.com/issues/1999/08_99/danila.htm
6. Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and
   public health communities. Emerg Infect Dis 2003; 9(7): 781-787.
7. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine--
   United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48(27):577-581.

To Top

1. Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease--United States. MMWR Morb Mortal Wkly Rep 1996; 45(31):665-668.
2. Virata M, Rosenstein NE, Hadler JL, Barrett NL, Tondella ML, Mayer LW et al. Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection. Clinical Infectious Diseases 27(5):1238-40, 1998.
   Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v27n5/no23_1238/no23_1238.
   web.pdf
3. Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM. Vancomycin in Oregon: who's using it and why. Infect Control Hosp Epidemiol 1999; 20(8):557-560.
4. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children
   --United States, 1990-1998. MMWR - Morbidity & Mortality Weekly Report 48(12):243-8, 1999.
5. Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men. American Journal of Public Health 2000; 90(12):1942-1946.
   Copyright held by APHA, posted with permission Download PDF [5 pages, 106 KB]
6. Centers for Disease Control and Prevention. Human rabies--California, Georgia, Minnesota, New York,
   and Wisconsin, 2000. MMWR - Morbidity & Mortality Weekly Report 49(49):1111-5, 2000.
7. Williams LK, Reichert A, MacKenzie WR, Hightower AW, Blake PA. Lice, nits, and school policy. Pediatrics 2001; 107(5):1011-1015.
8. Jacoby D, St Louis T, Navarro V. Hepatitis C practice routines among Connecticut's naturopathic physicians. American Journal of Gastroenterology 2001; 96(9):2801-2802.
9. Navarro VJ, St Louis T, Bell BZ, Sofair AN. Chronic liver disease in the primary care practices of Waterbury, Connecticut. Hepatology 2003; 38(4):1062. Open Access:http://www3.interscience.wiley.com/cgi-bin/abstract/106596004/ABSTRACT
10. Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. Journal of Clinical Gastroenterology 2003; 36(5):431-435.
    Posted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 332KB]
11. Jones JL, Ogunmodede F, Scheftel J, Kirkland E, Lopez A, Schulkin J et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infectious Diseases in Obstetrics & Gynecology 11(3):139-45, 2003.
12. Louie JK, Gavali SS, Belay ED, Trevejo R, Hammond LH, Schonberger LB et al. Barriers to Creutzfeldt-
    Jakob disease autopsies, California. Emerg Infect Dis 2004; 10(9):1677-1680.
13. Townes JM, Hoffmann CJ, Kohn MA. Neurocysticercosis in Oregon, 1995-2000. Emerging Infectious Diseases 10(3):508-10, 2004.

To Top

Bibliography by Activity: Respiratory Diseases Activity (RDA)

1. Slavin KA, Passaro DJ, Hacker JK, Hendry RM, Kohl S. Parainfluenza virus type 4: case report and review of the literature. [Review] [10 refs]. Pediatr Infect Dis J 2000; 19(9):893-896.
   Reprinted with permission from Lippincott, Williams & Wilkins. [slavin-2000-parainflu type 4 case rept and review.html]
2. Louie JK, Hacker JK, Mark J, Gavali SS, Yagi S, Espinosa A et al. http://www.cdc.gov/ncidod/EID/
   vol10no6/03-0863.htm. Emerging Infectious Diseases 10(6):1143-6, 2004.

To Top

Bibliography by Activity: Syndrome Projects (UNEX, Encephalitis, etc.)

1. Perkins BA, Flood JM, Danila R, Holman RC, Reingold AL, Klug LA et al.Unexplained deaths due to
   possibly infectious causes in the United States: defining the problem and designing surveillance
   and laboratory approaches. The Unexplained Deaths Working Group. Emerging Infectious Diseases 1996; 2(1):47-53.
2. Huang C, Thompson WH, Karabatsos N, Grady L, Campbell WP. Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes. Virus Research 1997; 48(2):143-148. Reprinted from Virus Research, Vol. 48, Huang et al, Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes, ©2002, with permission from Elsevier.
   http://www.sciencedirect.com/science/journal/01681702 Download PDF [6 pages, 354 KB]
3. Perkins BA, Relman D. Explaining the unexplained in clinical infectious diseases: looking forward. Emerging Infectious Diseases 1998; 4(3):395-397.
4. Huang C, Campbell W, Grady L, Kirouac I, LaForce FM. Diagnosis of Jamestown Canyon encephalitis by polymerase chain reaction. Clinical Infectious Diseases 1999; 28(6):1294-1297.
   Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v28n6/ju25_1294/ju25_1294.web.pdf
5. Huang C, Chatterjee NK, Grady LJ. Diagnosis of viral infections of the central nervous system. New England Journal of Medicine 1999; 340(6):483-484.
6. Park SY, Glaser C, Murray WJ, Kazacos KR, Rowley HA, Fredrick DRet al.Raccoon roundworm
   (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics 2000; 106(4):E56.
7. Rainbow J, Lynfield R, Johnson JR, Danila RN. Minnesota surveillance for unexplained deaths and critical illnesses of possible infectious cause. Minnesota Medicine 2000; 83(1):51-53.
   Open Access: http://www.mnmed.org/publications/MnMed2000/January/Rainbow.cfm
8. Centers for Disease Control and Prevention. Suspected brucellosis case prompts investigation of
   possible bioterrorism-related activity--New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Wkly Rep 2000; 49(23):509-512.
9. Centers for Disease Control and Prevention. Unexplained illness and death among injecting-drug
   users--Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49(22):489-492.
10. Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness
    among injecting-drug users--Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49(24):543-545.
11. Eldridge BF, Glaser C, Pedrin RE, Chiles RE. The first reported case of California encephalitis in more
    than 50 years. Emerging Infectious Diseases 2001; 7(3):451-452.
12. Kluger MD, Sofair AN, Heye CJ, Meek JI, Sodhi RK, Hadler JL. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut. American Journal of Public Health 2001; 91(8):1214-1219.
    Copyright held by APHA, posted with permission Download PDF [6 pages, 169 KB]
13. Schuster FL , Glaser C, Gilliam S, Visvesvara GS. Survey of sera from encephalitis patients for Balamuthia mandrillaris antibody. Journal of Eukaryotic Microbiology Suppl:10S-12S, 2001.
14. Centers for Disease Control and Prevention. Update: Unexplained deaths following knee surgery--
    Minnesota, 2001. MMWR Morb Mortal Wkly Rep 2001; 50(48):1080.
15. Passaro DJ, Shieh WJ, Hacker JK, Fritz CL, Hogan SR, Fischer M et al. Predominant kidney involvement in a fatal case of hantavirus pulmonary syndrome caused by Sin Nombre virus. Clin Infect Dis 2001; 33(2):263-264. Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n2/001329/001329.html
16. Price NO, Hacker JK, Silvers JH, Crawford-Miksza L, Hendry RM, Flood J et al. Adenovirus type 3 viremia in an adult with toxic shock-like syndrome.[comment]. Clin Infect Dis 2001; 33(2):260-262.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n2/001246/001246.html
17. Lynch M, Lee B, Azimi P, Gentsch J, Glaser C, Gilliam S et al. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis 2001; 33(7):932-938.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v33n7/001586/001586.html
18. Hajjeh RA, Relman D, Cieslak PR, Sofair AN, Passaro D, Flood J et al.Surveillance for unexplained deaths
    and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerging Infectious Diseases 2002; 8(2):145-153.
19. Lance-Parker S, Rebmann C, Kramer S, Kelly R. Arboviruses in Georgia. Emergence of West Nile Virus. Journal of the Medical Association of Georgia 91(2):32-4, 2002.
20. Meek J. West Nile virus in the United States. [Review] [35 refs]. Current Opinion in Pediatrics 2002; 14(1):72-77.
    Posted with permission from Lippincott, Williams & Wilkins. Download PDF [7 pages, 713KB]
21. Nikkari S, Lopez FA, Lepp PW, Cieslak PR, Ladd-Wilson S, Passaro D et al.Broad-range bacterial
    detection and the analysis of unexplained death and critical illness. Emerging Infectious Diseases 2002; 8(2):188-194.
22. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clinical Infectious Diseases 2002; 34(8):1154-1157.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v34n8/011216/011216.html
23. Lu HZ, Bloch KC, Tang YW. Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep 2002; 4(4):339-350.
24. Mullen L, Barry J, Igoe D, Keenan E, Ward M, Murray K. Unexplained illness among injecting drug users in Dublin: a case-control study. Journal of Epidemiology & Community Health 2002; 56(8):575-576.
    Open Access: http://jech.bmjjournals.com/cgi/content/full/56/8/575
25. Centers for Disease Control and Prevention (CDC). From the Centers for Disease Control and Prevention. Update: allograft-associated bacterial infections--United States, 2002. JAMA 2002; 287(13):1642-1644.
26. Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections--
    United States, 2002. MMWR - Morbidity & Mortality Weekly Report 2002; 51(10):207-210.
27. Bakardjiev A, Glaser C, Schuster F, Visvesvara GS. Three-year-old girl with fever and coma. Pediatric Infectious Disease Journal 21(1):75, 85-6, 2002. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [12 pages, 270 MB]
28. Schuster FL , Dunnebacke TH, Booton GC, Yagi S, Kohlmeier CK, Glaser C et al. Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. Journal of Clinical Microbiology 41(7):3175-80, 2003. Open Access: http://jcm.asm.org/cgi/content/full/41/7/3175
29. Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clinical Infectious Diseases 2003; 36(6):731-742.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v36n6/30040/30040.html
30. Bakardjiev A, Azimi PH, Ashouri N, Ascher DP, Janner D, Schuster FL et al. Amebic encephalitis caused by Balamuthia mandrillaris: report of four cases. Pediatric Infectious Disease Journal 2003; 22(5):447-453. Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [6 pages, 353 KB]
31. Centers for Disease Control and Prevention (CDC). Severe morbidity and mortality associated with
    influenza in children and young adults--Michigan, 2003. MMWR Morbidity & Mortality Weekly Report 2003; 52(35):837-840.
32. Dunnebacke TH, Schuster FL, Yagi S, Booton GC. Isolation of Balamuthia amebas from the environment. Journal of Eukaryotic Microbiology 50 Suppl:510-1, 2003.
33. Weitkamp JH, Spring MD, Brogan T, Moses H, Bloch KC, Wright PF. Influenza A virus-associated acute necrotizing encephalopathy in the United States. Pediatric Infectious Disease Journal 2004; 23(3):259-263.
    Reprinted with permission from Lippincott, Williams & Wilkins. Download PDF [5 pages, 792KB]
34. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, Patel JB et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clinical Infectious Diseases 2004; 38(6):799-804.
    Open Access:http://www.journals.uchicago.edu/CID/journal/issues/v38n6/31850/31850.html
35. Schuster FL , Glaser C, Honarmand S, Maguire JH, Visvesvara GS. Balamuthia amebic encephalitis risk,
    Hispanic Americans. Emerging Infectious Diseases 10(8):1510-2, 2004.
36. Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. Journal of Infectious Diseases 2005;(2):234-237.

To Top

Bibliography by Activity: Tick-Borne Disease Surveillance Activities

1. Meek JI, Roberts CL, Smith EV, Jr., Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. Journal of Public Health Management & Practice 2(4):61-5, 1996.
2. Heimer R, Van Andel A, Wormser GP, Wilson ML. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. Journal of Clinical Microbiology 1997; 35(4):923-927.
   Open Access:http://jcm.asm.org/cgi/content/abstract/35/4/923?maxtoshow=&HITS=10&hits=10&
   RESULTFORMAT=&author1=heimer,+r&searchid=1062614128544_3899&stored_search=&FIRSTINDEX=
   0&search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
3. IJdo JW, Zhang Y, Hodzic E, Magnarelli LA, Wilson ML, Telford SR, III et al. The early humoral response in human granulocytic ehrlichiosis. Journal of Infectious Diseases 1997; 176(3):687-692.
   Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v176n3/se50_687/se50_687.web.pdf
4. IJdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infection & Immunity 1998; 66(7):3264-3269.
   Open Access:http://iai.asm.org/cgi/content/full/66/7/3264?maxtoshow=&HITS=10&hits=10&RESULT
   FORMAT=&author1=ijdo&searchid=1062612556634_1684&stored_search=&FIRSTINDEX=0&journal
   code=iai
5. Magnarelli LA, IJdo JW, Anderson JF, Padula SJ, Flavell RA, Fikrig E. Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. Journal of Clinical Microbiology 1998; 36(10):2823-2827.
   Open Access:http://jcm.asm.org/cgi/content/full/36/10/2823?maxtoshow=&HITS=10&hits=10&RESULT
   FORMAT=&author1=magnarelli+la&searchid=1062614172122_3903&stored_search=&FIRSTINDEX=0
   &search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
6. Magnarelli LA, IJdo JW, Dumler JS, Heimer R, Fikrig E. Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. Journal of Infectious Diseases 1998; 178(6):1835-1838.
   Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v178n6/980461/980461.html
7. Heimer R, Tisdale D, Dawson JE. A single tissue culture system for the propagation of the agents of the human ehrlichioses.[comment]. American Journal of Tropical Medicine & Hygiene 1998; 58(6):812-815. Posted with permission from The American Society of Tropical Medicine and Hygiene. Download PDF [4 pages, 76 KB]
8. Centers for Disease Control and Prevention. Statewide surveillance for ehrlichiosis--Connecticut and
   New York, 1994-1997. MMWR - Morbidity & Mortality Weekly Report 1998; 47(23):476-480.
9. Chu FK. Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis. Mol Cell Probes 1998; 12(2):93-99.
10. Van Andel AE, Magnarelli LA, Heimer R, Wilson ML. Development and duration of antibody response against Ehrlichia equi in horses. J Am Vet Med Assoc 1998; 212(12):1910-1914.
11. IJdo JW, Wu C, Magnarelli LA, Fikrig E. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 1999; 37(11):3540-3544.
    Open Access:http://jcm.asm.org/cgi/content/full/37/11/3540?maxtoshow=&HITS=10&hits=10&RESULT
    FORMAT=&author1=magnarelli+la&searchid=1062614172122_3903&stored_search=&FIRSTINDEX=0
    &search_url=http://jcm.asm.org/cgi/search&journalcode=jcm
12. Magnarelli LA, Van Andel AE, IJdo JW, Heimer R, Fikrig E. Serologic testing of horses for granulocytic ehrlichiosis, using indirect fluorescent antibody staining and immunoblot analysis. American Journal of Veterinary Research 60(5):631-5, 1999.
13. IJdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, Fikrig E, Ryder RW. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. Journal of Infectious Diseases 2000; 181(4):1388-1393.
    Open Access:http://www.journals.uchicago.edu/JID/journal/issues/v181n4/991122/991122.html
14. Chaput EK, Meek JI, Heimer R. Spatial Analysis of Human Granulocytic Ehrlichiosis near Lyme,
    Connecticut. Emerging Infectious Diseases 2002; 8(9):943-948.

To Top

Open Access Articles

Biblographic entries noted above as "Open Access" are available, free to the public, through this Web page.